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In recent years a novel, nucleotide-based small molecule, c-di-GMP, has 
emerged in the spotlight of scientific investigation as a second messenger unique to 
the bacterial world. The discovery that its intracellular levels strictly regulate cell 
adhesion and persistence of bacterial biofilms on one hand, and motility and virulence 
of planktonic cells on the other, has related this RNA molecule to a variety of disease 
states including both chronic and acute bacterial infections. 
Interestingly, intracellular signaling mechanisms involving c-di-GMP appear to 
be spatially restricted, yet cellular targets for this nucleotide remain mostly unknown. 
Here we set out to identify and provide comprehensive structure-function analyses of 
putative or known c-di-GMP receptors. By using structural biology methods we would 
first determine the atomic resolution structures and conformational states of 
appropriate targets and then use these molecular blueprints to guide our research into 
their mechanistic role in the big picture of intracellular signaling networks. 
 We identified VpsT of V.cholerae as a novel c-di-GMP receptor and solved 
the crystal structures of the nucleotide-free and c-di-GMP-bound states. Our studies 
identified two biologically relevant dimerization interfaces and the potential formation 
of higher order oligomeric species assembling upon nucleotide recognition. VpsT 
defines a novel class of response regulators that utilize a characteristic structural 
feature to dimerize upon a signaling input regardless of concurrent phosphorylation 
 events. The relative orientation of the DNA-binding domains of VpsT favors a model 
in which gene regulation is likely accompanied by major changes in DNA 
architecture. We showed that VpsT is a master regulator of biofilm formation, 
integrating c-di-GMP signaling events to inversely control exopolysaccharide 
production and flagellar motility.  
 In a separate study, we provide a complete mechanistic analysis of the 
structure and function of LapD, a transmembrane c-di-GMP receptor in P. fluorescens 
which directly translates intracellular c-di-GMP levels in a signal for biofilm dispersal 
or initiation. We solved three novel crystal structures capturing distinct intermediates 
in the inside-out signaling process. Most importantly, our structural and functional 
analyses helped us identify homologous systems in a number of free-living and 
pathogenic species, likely controlling biofilm formation or toxin expression in a 
largely similar manner. 
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 CHAPTER  1 
 
 
Introduction 
 
1.1. C-di-GMP as a bacterial second messenger 
Cyclic di-GMP is a monocyclic RNA dinucleotide that functions as a global 
regulatory molecule found uniquely in bacteria. Approximately twenty years after its 
discovery by Benziman and colleagues as an allosteric activator of Gluconacetobacter 
xylinus cellulose synthase, c-di-GMP has gained appreciation as a universal second 
messenger triggering a plethora of physiological responses (1-4). Examples include 
cell differentiation, changes in motility and surface adhesiveness, secretion of 
extracellular polysaccharides and proteinaceous fimbriae, host cell cytotoxicity, and 
virulence gene expression (4-7). Signaling cascades employing this small molecule 
show evidence for multilayer impact which includes control at the transcriptional, 
translational and posttranslational levels. Proteins involved in c-di-GMP mediated 
signal transduction are often characterized by multi-domain architecture with such 
modularity to allow for a variety of regulatory inputs and/or signal ramifications (8, 
9). This complexity is in stark contrast with canonical two-component transduction 
systems, where upon signal generation a sensor histidine kinase phosphorylates its 
cognate response regulator to alter the expression of a limited number of genes (10).  
C-di-GMP is generated from two GTP molecules by GGDEF domain-
containing diguanylate cyclases, whereas phosphodiesterases containing either EAL 
or HD-GYP protein domains provide selective signal degradation (11-15). C-di-GMP 
turnover domains are found to be among the most abundant protein domains encoded 
in bacterial genomes. Interestingly, such abundance correlates with the ability of 
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 microbes to adapt to different ecological niches with opportunistic pathogens showing 
the largest number of c-di-GMP metabolizing enzymes per genome (9, 16). 
In general, increased intracellular c-di-GMP levels resulting from higher 
diguanylate cyclase activity lead to enhanced biofilm formation and inhibit flagellar 
and pilus-mediated motility (4, 18). Conversely, low levels of the nucleotide 
associated with active phosphodiesterase catalysis suppress the maintenance of 
extracellular adhesins and promote biofilm dispersion and bacterial virulence (19, 20). 
Although such an overall effect has been demonstrated in several overexpression 
studies, redundancy between different diguanylate cyclases or phosphodiesterases in a 
given genome is only apparent (12, 21). Oftentimes proteins with similar domain 
architecture or enzymatic activity trigger distinct physiological responses (11, 22). 
This is particularly surprising if one assumes that, as a small hydrophilic molecule, c-
di-GMP is freely diffusible in the cell. A number of studies argue instead that once 
generated, c-di-GMP is a sequestered, rather than general, diffusive signal (2, 4). 
Measurements of the intracellular levels of c-di-GMP in several bacterial species 
indicate concentrations in the micromolar range or lower, without taking into account 
probable local fluctuations. Based on the fact that most identified c-di-GMP receptors 
and phosphodiesterases have lower affinity constants for the nucleotide, it has been 
hypothesized that cellular c-di-GMP exists primarily in a protein bound form (2, 12). 
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Figure 1.1: Cyclic di-GMP as a signaling molecule.  
(A) Phylogenetic distribution of prevalent RNA-based second messengers: Signal 
transduction networks that rely on the monocyclic nucleotide second messengers 
cAMP and cGMP modulate a diverse range of cellular responses in all three domains 
of life. Recent work has identified two novel RNA dinucleotides that function as 
intracellular signal amplifiers: c-di-AMP utilized by both domains of prokaryotes, and 
c-di-GMP found uniquely in bacteria (17).  
(B) Cyclic di-GMP turnover domains in model opportunistic pathogens: Vibrio 
cholerae, causative agent of the acute diarrheal disease cholera, and Pseudomonas 
aeruginosa, causing persistent infections and lethality in patients with cystic fibrosis. 
(C) Cyclic di-GMP signal generation, recognition and degradation: While protein 
domains catalyzing c-di-GMP synthesis and hydrolysis have been fairly well 
characterized, nucleotide sensors decoding the signal to inversely regulate bacterial 
quorum sensing and biofilm formation are mostly unknown. 
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 1.2. Bacterial cyclic-di-GMP receptors 
Whether functioning as intermediaries in nucleotide signal relay or as final 
effectors in signaling cascades, bacterial c-di-GMP receptors remain largely unknown. 
Initial in silico prediction later corroborated by experimental evidence identified PilZ 
domains as the first known c-di-GMP targets (23-28). The domains are expressed 
either alone or as fusions with other modules, including but not restricted to EAL, 
GGDEF, HD-GYP, PAS and helix-turn-helix motifs (23). A PilZ domain was also 
identified as the c-di-GMP binding module in G. xylinus cellulose synthase, where c-
di-GMP regulator function was first reported (23). Phylogenetic and structural 
analyses showed that PilZ domains have low sequence conservation apart from a few 
interspersed residues responsible for nucleotide docking (25). Most importantly, PilZ 
domains could not be the only c-di-GMP targets as some species utilizing c-di-GMP 
mediated signaling do not encode for PilZ domain-containing proteins (23).  
Another c-di-GMP binding motif was identified on some diguanylate cyclases, 
where binding of the nucleotide to the so-called I-site leads to inhibition of enzymatic 
activity (29-31). A similar I-site motif (RxxD) is responsible for c-di-GMP binding in 
two other c-di-GMP receptors, PleD of P. aeruginosa and CdgG of V. cholerae, likely 
a part of degenerate diguanylate cyclase domains based on sequence alignment and 
secondary structure prediction (32, 33). Degenerate c-di-GMP specific phospho-
diesterase domains have also been reported to function as sensors for the nucleotide, 
as in the case with the P. aeruginosa FimX protein where the EAL domain module 
functions as a high-affinity nucleotide sensor to regulate biofilm formation and pilus-
mediated motility in a yet unknown mechanism (34). This, together with the many 
catalytically inactive GGDEF, EAL and HD-GYP domains identified, raises the 
question to what extent divergent c-di-GMP turnover domains have preserved signal 
transduction function based on nucleotide-dependent protein-protein interactions.  
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Figure 1.2: Diversity of cyclic di-GMP sensors and adopted nucleotide 
conformations.  
(A) Crystal structure of the diguanylate cyclase WspR, regulating biofilm formation 
in Pseudomonas aeruginosa (pdb entry: 3BRE) (30). C-di-GMP binds to an allosteric 
inhibitory “I” site to regulate its own catalytic synthesis. The nucleotide forms 
intercalated dimers (box), each of which recognizes the characteristic I-site RxxD 
motif of a GGDEF domain, plus additional residues from the GGDEF domain of a 
symmetry-related protomer. The latter nucleotide-mediated interprotomer interactions 
are likely to stabilize a catalytically inactive quaternary assembly (30).  
(B) Crystal structure of the Vibrio cholerae protein VCA0042 containing a PilZ 
domain in complex with c-di-GMP (pdb entry: 2RDE). Each protein subunit binds a 
single c-di-GMP molecule, whose distinct conformation is shown in the box below 
(25). Interestingly, although capable of c-di-GMP recognition, PilZ domain-
containing proteins are not essential for Vibrio cholerae biofilm formation (33).  
(C) Cyclic di-GMP binding to the EAL domain of FimX reveals alternative 
nucleotide conformation (box) and confirms the capacity of degenerate c-di-GMP 
turnover domains to serve as sensors for the nucleotide (pdb entry: 3HV8) (34).  
(D) C-di-GMP base-stacking propensity is a mechanism for nucleotide recognition by 
a Vibrio cholerae riboswitch (pdb entry: 3IWN) (35). 
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 Contributing to the complexity of identified c-di-GMP receptors, two other 
protein c-di-GMP targets have been recently identified: the transcription factor FleQ 
of Pseudomonas aeruginosa, and the catabolite activator-like protein Clp of 
Xanthomonas campestris (37-39). FleQ is an enhancer-binding protein with an N-
terminal receiver domain, an AAA σ54 interaction domain, and a C-terminal helix-
turn-helix DNA-binding motif (36, 37). Cyclic di-GMP recognition is shown to occur 
independently of the N-terminal receiver domain, but other than that nothing is known 
about the mode of protein-nucleotide interaction (37). Although the crystal structure 
of Clp has been recently solved, data regarding c-di-GMP recognition is limited and 
relies on merely computational models. While Clp contains a relatively conserved N-
terminal cyclic nucleotide monophosphate binding domain, responsible for cAMP 
recognition in its E. coli homolog, c-di-GMP is proposed to bind Clp at an allosteric 
site, formed at the interface between the N-terminal domain and the C-terminal DNA-
binding module (39). 
Although limited in number, identified c-di-GMP targets are characterized by 
an obvious diversity and multilevel impact. The recent identification of a widespread 
c-di-GMP responsive riboswitch class in messenger RNAs adds another layer of 
complexity to the mechanisms of c-di-GMP function (40). Structural information 
regarding the precise mode of nucleotide recognition is limited to some highly 
divergent PilZ domains (25, 27, 28), the catalytically inactive FimX of Pseudomonas 
aeruginosa (34), some I-site containing diguanylate cyclases (29, 30), and 
riboswitches from Vibrio cholerae (35, 41). Whether there are a limited number of 
universal c-di-GMP binding motifs, or individual receptors have evolved specific 
modes of recognition to ensure signal isolation, remains to be further investigated. In 
any case, c-di-GMP effectors represent a crucial part of bacterial signaling circuits 
and therefore an important target for therapeutic design and development. 
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 1.3. Clinical significance of c-di-GMP mediated processes 
Opportunistic bacterial pathogens are causative agents for a variety of human 
diseases or disease accompanying infections. Their ability to sense and respond to 
different microenvironments, particularly during transition from free-living to 
indwelling pathogenic lifestyle, is largely dependent on a variety of adaptational 
strategies. Examples include phenotypic variation, biofilm formation, resistance to 
antibiotic treatments and virulence gene expression (4, 6, 20, 42-49). A number of 
studies have suggested that these are interlinked phenotypes, largely dependent on c-
di-GMP mediated signaling phenomena (4). 
Bacterial biofilm formation describes the process of surface attachment of 
planktonic cells to form sessile multicellular communities, where an extracellular 
matrix of exopolysaccharides, proteinaceous fimbriae and DNA provides protection 
from environmental insults and a medium for intercellular communication. On the 
cellular level, functional differentiation, genomic rearrangements, changes in motility, 
cell adhesion, and secretion are among the many processes accompanying the 
transition to a biofilm life style.  Recent advances have identified biofilm formation as 
a multiphase process of collaborative group behavior, where distinct expression 
profiles reflect the progression through the biofilm cycle. This suggests that biofilm 
formation is a highly specialized developmental process, subject to strict temporal and 
spatial regulation (5, 48-50).  
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Figure 1.3: Overview of bacterial biofilm formation. Bacteria can reversibly attach 
to surfaces upon which loss of motility and synthesis of cellular adhesins provides 
strong anchorage and protective environment. Mature biofilms are developed within a 
certain time frame and are characterized by colony variance, complex architecture, 
and collaborative group behavior between functionally differentiated members. 
Finally, dispersion processes governed by the secretion of glycolipid surfactants, and 
ramnolipids in particular, lead to the release of highly motile planktonic cells, capable 
to colonize new surfaces (5, 51, 52).  
 
Widespread in the environment, biofilms can develop on a variety of biotic 
and abiotic surfaces. Biofilm formation on indwelling prosthetic devices and infected 
luminal organs has been recognized as a major cause for chronic bacterial diseases 
(45). Examples include infections of the inner ear (otitis media), heart (bacterial 
endocarditis), and lungs (Legionnaire’s disease and other pneumonias) of otherwise 
healthy individuals, as well as opportunistic infections contributing to the disease 
pattern of immunocompromised patients, such as in cases of AIDS, cancer, or cystic 
fibrosis (7, 44, 53). A hallmark of the latter genetic disorder is that patients succumb 
at a very young age to persistent lung infections by Pseudomonas aeruginosa, an 
organism commonly found in nature. It is now becoming increasingly evident that 
under c-di-GMP control, the lower respiratory tract of these individuals becomes 
 9
 colonized by dense bacterial biofilms, characterized by partial or complete oxygen 
depletion and induced expression of antibiotic resistances (48, 54).  
The other end of the spectrum of bacterial pathogenicity is represented by 
acute infections, characterized by short spikes in bacterial virulence. Interestingly 
enough, a single microorganism has oftentimes the ability to choose between the two 
modes, chronic and acute, of in-host propagation (6). Pseudomonas aeruginosa for 
example, is in some cases capable to cause acute pneumonia, breaking down host 
defenses and disseminating in the bloodstream within hours or days post infection. 
This is in stark contrast with cases of cystic fibrosis where the pathogen rarely if ever 
reaches the bloodstream, indicating that the acute versus chronic modes of infection 
are indeed quite distinct (6). As opposed to biofilms, systemic bacteremia during 
acute-phase pneumonia is caused by highly motile bacteria, which release a variety of 
extracellular toxins and quorum sensing molecules (55, 56). A number of studies have 
suggested c-di-GMP dependent reciprocal regulation of the biofilm forming and 
virulence phenotypes but the exact mechanisms through which pathogens choose 
between possible lifestyles remain largely unknown. 
Studies on Vibrio cholerae, an organism indigenous to aquatic biotopes and 
causative agent of the diarrheal disease cholera, have helped to shed light on the 
mechanisms controlling the switch between biofilm formation and acute-phase 
bacterial virulence. Biofilm formation by this facultative pathogen has been shown to 
increase its resistance to osmotic and oxidative stress, protozoan grazing and 
acidification (57). It has therefore been suggested that Vibrio cholerae exists in the 
environment and enters the human host primarily in the form of biofilms, which 
secure passage through the acidic environment of the stomach en route to the 
intestinal tract (58). Once in the small intestine, however,  the pathogen needs to 
actively repress its biofilm forming capacity in order for expression of virulence 
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 determinants to occur (20, 46). On the molecular level this is achieved by the catalytic 
reduction of intracellular c-di-GMP levels through the specific function of one or 
more phosphodiesterases (59). Although the trigger for this catalytic activity remains 
unknown, some of the downstream signaling targets are now beginning to emerge. As 
discussed in the next chapter, we recently identified VpsT, a master transcriptional 
regulator of Vibrio cholerae biofilm formation, as a novel c-di-GMP binding receptor 
(60). This raises the possibility that VpsT and other transcription factors directly 
respond to changes in cellular c-di-GMP concentration to cause transition between 
different lifestyles through large-scale shifts in gene expression. In addition, a recent 
study identified a riboswitch class in mRNA which senses reduction in c-di-GMP 
levels to allow for expression of one of the main Vibrio cholerae virulence 
determinants (40). 
In conclusion, opportunistic pathogens are able to rapidly adapt their 
physiology and virulence potential to the specific microconditions they encounter in 
the host, regardless of their environmental reservoir. On the molecular level this is 
achieved through various intracellular signaling cascades employing c-di-GMP as a 
second messenger. The overall scheme where c-di-GMP reciprocally regulates cell 
adhesion and persistence of biofilm forming communities on one hand, and motility 
and virulence of planktonic cells on the other, places c-di-GMP signaling mechanisms 
as an important target in the fight against both chronic and acute bacterial diseases. 
 
1.4. Model organisms for the study of c-di-GMP mediated signal transduction 
According to recent World Health Organization reports, infectious diseases of 
bacterial origin contribute to some of the leading mortality causes worldwide. These 
include gastroenteric diseases, obstructive pulmonary infections, and AIDS-derived 
opportunistic infections among others (61). Bacterial biofilm formation represents an 
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 important obstacle to the treatment and prevention of infectious diseases, as it has 
been estimated that 60-80% of chronic infections can be attributed to biofilm 
persistence. The elucidation of the underlying signaling phenomena is therefore of 
immediate clinical significance, whereas the choice of appropriate model systems is 
of primary consideration. 
 
Table 1.1: The leading causes of death worldwide by broad income group, 2004 (61).   
 
 
 
 
 
 
 
 
 
Bacterial biofilms can be classified according to their member species as 
hetero- or homobiofilms. While in the former case the collaborative community is 
comprised of different microbial species contributing specific metabolic and structural 
features, the latter indicates sufficiency of a single species to provide and coordinate 
all functions necessary for biofilm initiation, growth, and propagation (62, 63). 
We chose Pseudomonas aeruginosa, its related species Pseudomonas 
fluorescens, and the facultative enteric pathogen Vibrio cholerae as the primary model 
organisms for our studies (30, 60, 64). All three species opt for the formation of 
homobiofilms in their natural environmental habitats, indicating that all components 
necessary for this process are encoded in a fully functional form by their individual 
genomes. The latter have been fully sequenced, and in the cases of Vibrio cholerae 
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 and Pseudomonas aeruginosa sequences from clinical isolates are readily available.  
Vibrio cholerae represents an important model system to study the dynamic 
interplay between biofilm formation and acute-phase bacterial virulence. It is 
causative agent of the potentially lethal diarrheal disease cholera, seasonal outbreaks 
of which continue to scourge the world’s population. This places Vibrio cholerae as a 
human pathogen of primary clinical significance and makes it a preferred model 
organism for our structural and functional studies (60). Pseudomonas aeruginosa is 
another important human pathogen, which colonizes mainly immunocompromised 
individuals such as burnt victims and patients with cystic fibrosis. It provides an 
important model system for studying the role of biofilm formation in chronic bacterial 
infections, and in particular in the case of obstructive pulmonary diseases. Many of 
the intracellular signaling events involved in Pseudomonas aeruginosa c-di-GMP 
mediated pathogenicity are replicated in its closely related species Pseudomonas 
fluorescens. However, rather than being pathogenic, biofilm formation by this 
organism contributes to its beneficial biocontrol properties, underscoring the various 
aspects of this signaling process. More importantly, our studies of a Pseudomonas 
fluorescens c-di-GMP receptor helped us identify a number of homologous systems, 
likely regulating biofilm formation and toxin secretion in various pathogenic species 
(64).  
 
1.5. Protein targets of interest 
 Using the Gram-negative species Pseudomonas aeruginosa, Pseudomonas 
fluorescens, and Vibrio cholerae as model systems, we set out to decipher signal 
transduction pathways controlling bacterial pathogenesis, especially in the context of 
c-di-GMP signal recognition. Based on recent reports in the literature (32, 33, 37, 42, 
54, 57, 65-67), as well as on personal communication with our collaborators, we 
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 chose several putative and known c-di-GMP targets as a focus of our structural and 
functional studies. Overall, they can be divided in two classes based on the level of c-
di-GMP signaling impact. Whereas the first class represents several transcription 
factors that function as global regulators at the gene expression level, the second 
contains proteins with degenerate c-di-GMP turnover domains that have shown strong 
effects on biofilm formation or virulence upon knockout, overexpression, or 
mutational studies. In the current model, these proteins function on the post-
translational level to ensure c-di-GMP signal relay through direct protein-protein 
interactions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Conserved domain organization of putative and known c-di-GMP 
receptors. Above, CsgD-like and AAA+ σ54-interaction domain-containing 
transcription factors involved in c-di-GMP mediated signal transduction. Below, 
degenerate c-di-GMP turnover domains as another class of putative c-di-GMP 
sensors, with divergent GGDEF, EAL, or HD-GYP domains likely involved in c-di-
GMP signal recognition (68, 69). 
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A member of the first class of putative c-di-GMP targets is VpsT of Vibrio 
cholerae. VpsT was first identified as a transcription regulator required for the 
expression of Vibrio exopolysaccharide biosynthesis genes (clusters vpsA-K and  
vpsL-Q on the large Vibrio chromosome), which are required for the development of 
biofilms and rugose colony morphology (42, 57). VpsT shares high percent sequence 
identity with CsgD of Escherichia coli and Salmonella typhimurium, required itself 
for the secretion of the two major extracellular matrix components, 
exopolysaccharides and proteinaceous fimbriae (curli) (43, 70). Based on sequence 
homology CsgD is classified as a member of the FixJ/LuxR family of prokaryotic 
response regulators. The latter are typically part of archetypal two-component 
transduction systems, using phosphoryl transfer from upstream kinases as input 
signals for transcription regulation (71). Interestingly, CsgD contains a divergent 
receiver domain, where only half of the amino acids involved in phosphoryl transfer 
are conserved (Fig. 2.13B) and no cognate histidine kinase has been identified to date 
(42, 60, 72). Recent work has shown that CsgD can autophosphorylate in the presence 
of acetyl phosphate in vitro, but no such role for this high-energy phosphodonor has 
been identified in vivo (73).   
As mentioned above, physiological responses following c-di-GMP signal 
generation appear to be spatially restricted, regardless of the high solubility and small 
size of this intracellular second messenger (4, 74-76). Regulation of CsgD represents 
an important example of c-di-GMP signal isolation: Although expression of the 
Salmonella typhimurium csgD gene responds to elevated c-di-GMP levels, it is not 
influenced by knockout of the adrA gene, whose protein product is a diguanylate 
cyclase contributing for over half of the cellular c-di-GMP pool. Rather, csgD 
expression is controlled by two additional diguanylate cyclases which by themselves 
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 have no significant effect on the global c-di-GMP concentration (74).  
Similarly to CsgD, VpsT of Vibrio cholerae regulates the expression of 
extracellular matrix components, has a divergent receiver domain, and lacks an 
associated sensor kinase (42). In addition, regulation by VpsT has been previously 
linked to c-di-GMP mediated signal transduction, and vpsT gene expression is under 
positive control by its own protein product (42, 57).  
Based on the facts that VpsT stimulates its own transcription (42), that csgD 
expression in Escherichia coli and Salmonella typhimurium is controlled by the 
function of specific diguanylate cyclases (74, 76), and that small molecule binding has 
been previously postulated to enhance CsgD activity in vivo (71), we hypothesized 
that CsgD-like transcription regulators function as direct sensors for intracellular c-di-
GMP concentration and act downstream of diguanylate cyclases as endpoint signal 
effectors.   
VC0396 is another protein encoded by the Vibrio genome, which shares high 
percent sequence identity with VpsT (68, 70). While its role in biofilm formation 
remains to be experimentally determined, the fact that knockout of VpsT is sufficient 
for rugose to smooth morphotype conversion argues against functional redundancy 
between the two transcription regulators (42). Whether VpsT and VC0396 regulate 
distinct sets of genes, or they function at different stages of biofilm formation, 
represents yet another interesting question and underscores the rapid evolution and 
functional complexity of biofilm-related signaling pathways.  
Based on sequence homology to VpsT, we identified PA0533 of Pseudomonas 
aeruginosa as another potential c-di-GMP target (68, 70). Interestingly, the latter 
contains an additional PAS domain N-terminal to the putative c-di-GMP binding 
receiver domain. Considering that among PAS domains are heme-dependent oxygen 
sensors and that Pseudomonas aeruginosa biofilms in cystic fibrosis lungs are 
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 characterized by reduced or absent oxygen tension (54, 77), similar domain 
organization might serve to provide an important additional signaling input.  
The genome of Pseudomonas aeruginosa also encodes for several proteins 
that have been experimentally confirmed to function as c-di-GMP binding receptors 
(32, 34, 37). Among these is the σ54-dependent FleQ, identified as the first 
transcription factor to inversely regulate motility and extracellular matrix production 
in direct response to nucleotide recognition (37). When bound to DNA FleQ acts as a 
master activator of flagellar gene expression, as well as a repressor for the pel 
exopolysaccharide biosynthesis operon. This FleQ-DNA interaction is disrupted upon 
c-di-GMP recognition, which in turn leads to motility inhibition and biofilm 
formation (37). Interestingly, when we searched for FleQ homologs in other bacterial 
species (68), we stumbled upon VpsR of Vibrio cholerae, a positive regulator of vps 
synthesis and biofilm formation with an overall similar regulon as VpsT (57). 
Whether VpsR is another c-di-GMP target, or it relies on VpsT and/or VC0396 to 
introduce c-di-GMP sensitivity to the signaling network remains to be further 
investigated. Apart from the fact that the FleQ • c-di-GMP complex formation appears 
independent of the protein’s N-terminal receiver domain (37), c-di-GMP binding and 
concurrent conformational changes have remained largely uncharacterized. This, 
together with the biological significance of Pseudomonas aeruginosa FleQ and Vibrio 
cholerae VpsR as the pathogens’ global biofilm regulators, led us to pursue their 
structural and functional characterization in the light of c-di-GMP signal recognition.  
A separate class of c-di-GMP sensors comprises proteins with divergent, 
catalytically inactive c-di-GMP turnover domains. Examples include Pseudomonas 
FimX and LapD proteins where degenerate EAL domains function as the nucleotide 
sensor modules (19, 34), as well as Vibrio cholerae CdgG and Pseudomonas 
aeruginosa PelD, where c-di-GMP binds to the so-called I-site of inactive diguanylate 
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 cyclase domains (32, 33). The role of degenerate HD-GYP domains as potential c-di-
GMP receptors remains to be experimentally determined. A putative candidate is 
SadB of Pseudomonas aeruginosa, which functions at the initial stages of bacterial 
attachment to surfaces and is thus crucial for biofilm formation by the pathogen (65). 
SadB functions downstream of two specific c-di-GMP turnover enzymes, a 
diguanylate cyclase and a phosphodiesterase, which inversely control its effects on 
biofilm formation and swarming motility (66, 67). This, together with the fact that 
SadB contains a domain homologous to phosphodiesterase HD-GYP modules, 
presents the possibility that the latter can also serve as nucleotide sensors in various c-
di-GMP signaling pathways, rather than simply as enzymes providing selective signal 
degradation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: GGDEF and EAL domain abundance among bacterial genomes. Data 
retrieved from the SMART research database (78, 79). 
 
Catalytically active and degenerate c-di-GMP turnover domains are encoded 
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 in large numbers in bacterial genomes (Fig. 1.5) (9, 78, 79). Oftentimes, these are part 
of multidomain proteins, allowing for a variety of regulatory inputs and signal 
ramifications. Interestingly, almost a fourth of all GGDEF and EAL domain- 
containing proteins possess both types of domains in the same polypeptide chain 
where no, single, or dual catalytic activity can be preserved among protein family 
members. About 10% of these contain an additional HAMP domain N-terminal to the 
GGDEF-EAL domain tandem where HAMP domains function as juxtamembrane 
signal relay modules found in bacterial transmembrane receptors (80). One such 
receptor with a conserved HAMP-GGDEF-EAL domain organization is the 
previously mentioned LapD of Pseudomonas fluorescens, which controls cell 
adhesion and biofilm formation in a c-di-GMP dependent manner (19). Given the 
direct role for LapD as a bacterial c-di-GMP receptor, as well as the large abundance 
of proteins with similar domain architecture– especially in the context of related 
pathogenic species– we set out to decipher the structure and function of LapD 
homologs as c-di-GMP sensors in bacterial adaptation and virulence.  
In the following chapters we will present detailed structural and functional 
analyses of VpsT of Vibrio cholerae and LapD of Pseudomonas fluorescens as 
members of the two major classes of likely c-di-GMP sensors. In addition, we will 
outline current advances toward the structural studies of FleQ of Pseudomonas 
aeruginosa and propose an array of future experiments to help further characterize 
proteins responsible for bacterial c-di-GMP signal recognition.  
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 CHAPTER  2 
 
 
Preface 
 
The biofilm-forming capacity of Vibrio cholerae in natural aquatic habitats is 
well documented and predicted to be a survival strategy for the organism outside of 
the host body. It has also been recently reported that the average infectivity of the 
biofilm forming rugose variants of Vibrio cholerae is significantly higher than that of 
planktonic cells and that the biofilm life form secures survival of the pathogen in the 
acidic environment of the stomach en route to the intestinal tract. Biofilm formation 
and other processes contributing to pathogenicity are regulated by the bacterially 
unique second messenger cyclic di-GMP (c-di-GMP). While enzymes controlling 
cellular c-di-GMP levels have been identified in large numbers in the Vibrio cholerae 
genome, little is known regarding signal transmission and the targets of this signaling 
molecule. 
In the following work, "Vibrio cholerae VpsT regulates matrix production and 
motility by directly sensing cyclic di-GMP" by Petya Krasteva et al., we identify 
VpsT as a novel receptor for c-di-GMP signal transduction. By combining structural 
and functional approaches, we present several novel findings elucidating the 
molecular mechanism by which this transcriptional regulator controls a switch in 
bacterial life style through transition from free-swimming, motile existence to the 
sessile collaborative group behavior of biofilm formation. Our work identifies VpsT 
as a signal-integrating master regulator that inversely controls extracellular matrix 
production and flagellar motility. Interestingly, VpsT is not regulated by 
phosphorylation as established for canonical response receiver proteins, but employs a 
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 novel structural feature and small molecule binding for regulation. The structural 
analysis defines a new class of response receiver domains that includes other 
phosphorylation incompetent VpsT family proteins, the homologous CsgD from 
Salmonella and Escherichia coli, as well as canonical phosphorylation-dependent 
response regulators. In addition, the relative orientation of the DNA binding domains 
of VpsT in the functionally relevant oligomeric assemblies indicates that changes in 
DNA architecture are likely to accompany VpsT-dependent transcriptional regulation. 
The following work would not have been possible without the outstanding 
contributions from members of the Yildiz Lab at UC Santa Cruz and the Sondermann 
Lab at Cornell University. I am deeply grateful to Fitnat Yildiz and my mentor, Dr. 
Holger Sondermann, for help with the experimental design, data analysis, and 
manuscript writing; to Jiunn C. N. Fong and Nicholas J. Shikuma for conducting the 
cell-based experiments; to Sinem Beyhan for providing certain strains and reagents; 
and to Marcos V. A. S. Navarro for providing access to synchrotron data collection 
and for general advice in crystallographic data analysis.  
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 Vibrio cholerae VpsT regulates matrix production and motility by directly 
sensing cyclic di-GMP * 
 
Microorganisms can switch from a planktonic, free-swimming life style to a 
sessile, colonial state, called a biofilm, conferring resistance to environmental stress. 
Conversion between the motile and biofilm life style has been attributed to increased 
levels of the prokaryotic second messenger cyclic di-guanosine monophosphate (c-di-
GMP), yet the signaling mechanisms mediating such a global switch are poorly 
understood. Here we show that the transcriptional regulator VpsT from Vibrio 
cholerae directly senses c-di-GMP to inversely control extracellular matrix production 
and motility, identifying VpsT as a master regulator for biofilm formation. Rather 
than being regulated by phosphorylation, VpsT undergoes a change in oligomerization 
upon c-di-GMP binding. 
In Vibrio cholerae, biofilm formation is facilitated by colonial morphotype 
variation (1-4). Rugose variants produce increased levels of extracellular matrix via 
the expression of Vibrio polysaccharide (vps) genes and genes encoding matrix 
proteins. vps expression is under the control of two positive transcriptional regulators, 
VpsT and VpsR (5, 6). VpsT is a member of the FixJ/LuxR/CsgD family of response 
regulators, typically  effectors  in  two-component signal transduction systems that use 
* Reproduced with permission from [Petya V. Krasteva, Jiunn C.N. Fong, Nicholas J. 
Shikuma, Sinem Beyhan, Marcos V.A.S. Navarro, Fitnat H. Yildiz, and Holger 
Sondermann (2010) Science 327, 866-868] © 2010 Krasteva et al. 
 
Author contributions are as follows: P.V.K., F.H.Y. and H.S. designed research; 
P.V.K., J.C.N.F., and N.J.S. performed research; S.B. provided certain strains and 
reagents; P.V.K., J.C.N.F., N.J.S., M.V.A.S.N., F.H.Y., and H.S. analyzed data; and 
P.V.K., F.H.Y. and H.S. wrote the paper. 
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 phosphoryl transfer from upstream kinases to modulate response regulator protein 
activity (7-9). Although the putative phosphorylation site is conserved in VpsT’s 
receiver domain, other residues crucial for phosphotransfer-dependent signaling are 
not and no cognate kinase has been identified to date (Fig. 2.4). Regulation by VpsT 
and VpsR has been linked to signal transduction utilizing the bacterial second 
messenger c-di-GMP (10, 11) (Fig. 2.5), yet little is known about the direct targets of 
the nucleotide. A riboswitch has been identified as a c-di-GMP-target regulating gene 
expression of a small number of genes, but is unlikely to account for the global 
change in transcriptional profile required for biofilm formation (12). Neither do PilZ 
domain-containing proteins, potential c-di-GMP effectors, affect rugosity since a V. 
cholerae strain lacking all five PilZ domain-containing proteins retains its colony 
morphology and ability to overproduce vps gene products (13). 
VpsT consists of an N-terminal receiver (REC) and a C-terminal helix-turn-
helix (HTH) domain, with the latter mediating DNA binding (Fig. 2.1A; see 
Supplemental Information for details). Unlike other REC domains, the canonical 
(α/β)5-fold in VpsT is extended by an additional helix at its C-terminus (Fig. 2.1A; 
helix α6). The HTH domain buttresses against an interface formed by helices 3 and 4 
of the N-terminal regulatory domain. There are two non-overlapping dimerization 
interfaces between non-crystallographic VpsT protomers (chain A-chain B and chain 
A-chain Bsym; Fig. 2.1B). The c-di-GMP-independent interface involves interactions 
mediated by a methionine residue (M17) located at the beginning of α1 and a binding 
pocket that extends into the putative phosphorylation site of the REC domain (Fig. 
2.6A). The second interface involves α6 of the REC domain, in contrast to canonical 
response regulators such as CheY and PhoB that utilize a surface formed by α4-β5-α5 
for dimerization (9). The binding of two intercalated c-di-GMP molecules to the base 
of α6 stabilizes VpsT dimers utilizing this interface (Fig. 2.1 and 2.6B). 
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Figure 2.1: Crystal structure of VpsT. (A) Structure of a VpsT protomer. (B) 
Crystal structure of a crystallographic trimer representing two potentially relevant, 
non-overlapping dimerization interfaces. Cyclic di-GMP molecules are shown as 
sticks, key residues mediating ligand binding and interprotomer interactions are 
shown as spheres. (C) Close-up view of the nucleotide binding pocket with residues 
involved in coordinating the ligand shown as sticks. A (|Fo|-|Fc|) electron density map 
contoured at 3.6σ is shown as calculated from a model prior to inclusion of c-di-
GMP. 
 
The binding motif for c-di-GMP in VpsT consists of a 4-residue-long, 
conserved W[F/L/M][T/S]R sequence (Fig. 2.4). The side chains of the tryptophan 
and arginine form π-stacking interactions with the purine rings of the nucleotide (Fig. 
2.1C). While the hydrophobic residue in the second position plays a structural role 
being buried in the REC domain, the threonine residue at position 3 forms a hydrogen 
bond with the phosphate moiety of c-di-GMP. A subclass of VpsT/CsgD homologs 
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 exists with a proline substitution in position 3 (W[F/L/M]PR). Although CsgD is also 
functionally linked to c-di-GMP signaling in E. coli and Salmonella (14, 15), its 
binding pocket appears to be distinct from that of VpsT since it displays a highly 
conserved YF[T/S]Q motif that is unlikely to accommodate c-di-GMP (Fig. 2.6B). 
The apparent affinity of VpsT for c-di-GMP, determined by isothermal 
titration calorimetry, is 3.2 µM with 1:1 stoichiometry, consistent with a dimer of c-
di-GMP binding to a dimer of VpsT (Fig. 2.7A). Single-point mutations in the 
conserved c-di-GMP binding motif (VpsTR134A, VpsTW131F or VpsTT133V) or in the 
isoleucine in α6 of the c-di-GMP-stabilized REC dimerization interface (VpsTI141E) 
abolished c-di-GMP binding, indicating that dimeric REC domains are required for 
binding (Fig. 2.7B). Conversely, mutation of a key residue in the nucleotide-
independent interface (VpsTM17D) had no effect on c-di-GMP binding. Based on static 
multi-angle light scattering, VpsTM17D exists as a monomeric species in the absence of 
c-di-GMP, whereas intermediate molecular weights for the wild-type VpsT and the 
mutants VpsTR134A and VpsTI141E indicated fast exchange between monomers and 
dimers, presumably through the c-di-GMP-independent interface (Fig. 2.8 and Table 
S2). Addition of c-di-GMP increases the molecular weight of VpsTM17D and wild-type 
VpsT (Fig. 2.8 and 2.9) while the oligomeric state of VpsTR134A and VpsTI141E is 
insensitive to the nucleotide. 
The role of c-di-GMP recognition and the relevance of the two dimer 
interfaces in DNA-binding and VpsT-regulated gene expression was assessed by 
using c-di-GMP binding (R134) and dimerization (I141 or M17) mutants (Fig. 2.2). In 
electromobility shift assays we used regulatory sequences upstream of vpsL, a gene 
under positive control of VpsT (Fig. 2.2A) (6). DNA mobility shifts were observed 
only for the wild-type (wt) and VpsTM17D forms, where the effect was protein-specific 
and c-di-GMP-dependent. In addition, nucleotide-dependent DNA binding of VpsT 
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 was observed to multiple and relatively remote sites in the regulatory region of vpsL. 
To evaluate the functional importance of VpsT oligomers and c-di-GMP 
binding in cells, we measured transcription of vps genes by using a chromosomal 
vpsLp-lacZ transcriptional fusion in the ∆vpsT strain harboring wild-type VpsT, VpsT 
point mutants (VpsTM17D, VpsTR134A or VpsTI141E) or the insert-less expression vector 
(pBAD) (Fig. 2.2B). The presence of wild-type VpsT and VpsTM17D resulted in 
increased vpsL expression, similar to the wild-type rugose strain carrying vector only, 
while ∆vpsT strains with VpsTR134A, VpsTI141E or the empty vector did not exhibit 
such an increase. These data confirm that c-di-GMP-mediated oligomerization is 
critical for VpsT function. Mutations in the putative phosphorylation site designed to 
produce a constitutively inactive or active state, VpsTD60A or VpsTD60E, respectively, 
did not alter the efficiency of VpsT significantly. Hence, regulation of gene 
expression is presumably independent of phosphorylation of VpsT (see also Fig. 
2.10). 
Next, we determined the gene regulatory potential as a function of c-di-GMP 
binding and oligomerization through whole genome expression profiling by 
comparing a ∆vpsT strain harboring either wild-type VpsT or VpsT point mutants 
(VpsTM17D, VpsTR134A or VpsTI141E) to that of cells harboring the pBAD vector alone 
(Fig. 2.2C; Table S3). Genes located in the vps-I and vps-II clusters, as well as the vps 
intergenic region were strongly induced upon expression of wild-type VpsT and 
VpsTM17D, and significantly less so in the strains expressing VpsTR134A or VpsTI141E. 
We also observed that the expression of several genes encoding flagellar proteins was 
decreased in cells expressing wild-type VpsT and VpsTM17D but not in cells 
expressing VpsTR134A or VpsTI141E, suggesting that VpsT inversely regulates motility 
and matrix production in a c-di-GMP-dependent manner (Fig. 2.2C and 2.10). These 
results were corroborated in motility assays, in which a ∆vpsT strain or strains 
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 expressing c-di-GMP-binding mutants showed increased migration on soft agar plates 
compared to rugose strains that express VpsT forms that are competent of c-di-GMP-
dependent dimerization (Fig. 2.3A). 
The strain harboring VpsTM17D had a similar expression profile to the strains 
harboring wild-type VpsT however with increased magnitude, indicating that c-di-
GMP-independent dimerization could be inhibitory or regulatory (Fig. 2.2A and 
2.2C). In contrast, the c-di-GMP-dependent interaction between two VpsT monomers 
is sufficient and necessary for DNA recognition and transcriptional regulation. 
The corrugated appearance of rugose colonies can be attributed largely to 
increased levels of exopolysaccharides, which are induced by VpsT (6). As a 
consequence, V. cholerae mutants lacking vpsT produce smooth and flat colonies 
(Fig. 2.3B). To elucidate phenotypic consequences of mutations abolishing c-di-GMP 
binding and/or dimerization of VpsT, we compared the colony morphology of a 
∆vpsT strain harboring wild-type VpsT or one of the point mutants described above. 
Expression of wild-type VpsT and VpsTM17D resulted in smooth-to-rugose conversion, 
where spot corrugation was greater in a ∆vpsT strain harboring VpsTM17D compared to 
a strain with wild-type VpsT. Introduction of VpsTR134A, VpsTI141E or a double-mutant 
VpsTM17D/R134A failed to promote the smooth-to-rugose switch, but led to a distinct 
phenotype, characterized by increased spot diameter and weak corrugation with a 
notable radial pattern (Fig. 2.3B and 2.11). 
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Figure 2.2: Transcriptional regulation by VpsT.  
(A) Electromobility shift assays with purified proteins and biotin labeled fragments 
tiling the vpsL promoter region. Numbers indicate position relative to the open 
reading frame start.  
(B) vpsL gene expression in different genetic backgrounds harboring a single-copy 
chromosomal vpsLp-lacZ fusion. Data are mean of 8 replicates -/+ SD (Data courtesy 
of Jiunn C.N. Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
(C) Whole genome expression profiling. Top, compact heatmap in a log2-based 
pseudocolor scale (yellow, induced; blue, repressed) comparing a total of 108 
differentially expressed genes in a ∆vpsT strain expressing wild-type (wt) or mutated 
VpsT versions compared to the vector control. Midpanel, expression profiles of genes 
located in and between the vps-I and vps-II clusters; bottom, expression profiles of 
flagellar biosynthesis genes (Data courtesy of Jiunn C.N. Fong, Nicholas J. Shikuma, 
and Fitnat H. Yildiz). 
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Figure 2.3: Functional characterization of rugose wild-type, ∆vpsT strains, and 
∆vpsT strains expressing wild-type or mutant forms of VpsT.  
(A) Motility phenotypes on semisolid LB agar plates. For strains expressing mutants 
of VpsT, single chromosomal insertion mutants are shown. The graph shows the mean 
migration zone diameter of each strain. Data are mean of 11 replicates -/+ SD (Data 
courtesy of Jiunn C.N. Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
(B) Spot morphologies. A wild-type rugose strain carrying the vector (pBAD) and 
∆vpsT strains carrying the vector or plasmids containing wild-type or mutant vpsT are 
shown (top, unscaled; bottom, scaled to similar diameter; bars=1 mm) (Data courtesy 
of Jiunn C.N. Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
 
Cyclic di-GMP in the rugose variant is required for increased vps and VpsT 
gene expression (10, 11), suggesting that VpsT is involved in a positive feedback loop 
that integrates c-di-GMP to produce a robust transcriptional response. Robust matrix 
and biofilm formation relies on the mutual dependence of VpsT and VpsR, with VpsT 
introducing c-di-GMP-sensitivity to the regulatory network. In contrast, the 
transcriptional regulator FleQ from Pseudomonas aeruginosa, a distant VpsR-
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 homolog, appears to directly sense c-di-GMP independently of a VpsT-homolog by 
using a distinct c-di-GMP binding motif (16). 
Taken together, we establish VpsT as a transcriptional regulator that inversely 
regulates biofilm formation and motility by directly integrating c-di-GMP signaling. 
Cyclic di-GMP-driven dimerization is mediated by an extension of the canonical 
receiver domains, a structural motif that defines a wide-spread class of response 
regulators including CsgD and other LuxR family proteins. While some mechanisms 
may only pertain to close homologs of VpsT such as c-di-GMP-dependent 
dimerization, the general mode of action involving dimerization accompanied with 
changes in the relative orientation of the DNA binding domains is likely to be relevant 
for the large family of homologous transcription factors. 
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 APPENDIX  A 
 
 
Supplemental Information 
 
2.A1. Detailed Results and Discussion 
Additional structural analysis 
 VpsT is a 25.8 kDa, conserved protein in Vibrio with sequence similarity to 
CsgD, FixJ and other LuxR family transcriptional regulators. Full-length VpsT from 
V. cholerae was purified to homogeneity by using standard liquid chromatography 
(see Material and Methods for details). Crystallization trials carried out with VpsT in 
the absence or presence of c-di-GMP yielded isomorphous crystals with similar unit 
cell dimensions, space group and diffraction properties (Table 2.S1). 
For the nucleotide-free protein, crystals grown with selenomethionine-
substituted protein diffracted X-rays to a maximal resolution of 3.1 Å. Data sets were 
collected at 3 wavelengths: the selenium anomalous scattering peak wavelength, the 
inflection, and a remote wavelength. The structure was solved by multi-wavelength 
anomalous dispersion (MAD) phasing, determining the position of 28 out of 32 
selenium atoms. VpsT crystallized in the space group P41212 with 4 molecules in the 
asymmetric unit (Fig. 2.12). The polypeptide chain of protomers A, B and C could be 
traced and built with high confidence into the experimentally phased maps. The REC 
domain of molecule D was also well resolved. The HTH domain of molecule D was 
largely disordered, and only the position of two of the 4 helices could be determined. 
Cyclic di-GMP-bound VpsT diffracted X-rays to a resolution of 2.8 Å. The 
structure was solved by molecular replacement using a protomer of the nucleotide-
free structure as the search model. Four protomers could be located in the asymmetric 
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 unit with similar properties described above for apo-VpsT. The electron density maps 
revealed extra density at the base of the A-B and C-D dimer interfaces that was 
reminiscent of two stacked c-di-GMP molecules (Fig. 2.1C and 2.12A). A similar 
conformation of the nucleotide has been observed at the inhibitory site of diguanylate 
cyclases such as PleD and WspR, and in crystals of the nucleotide (S9, S12-14). 
Within a VpsT dimer, the two-fold symmetric c-di-GMP dimer stabilizes a two-fold 
symmetric protein assembly, using a similar binding mode as has been observed in 
other c-di-GMP-protein complexes that involves π-stacking interactions in addition to 
hydrogen bonds between the guanidinium groups of the binding site’s arginine 
residues and the central guanine bases of c-di-GMP (S9, S12). 
The asymmetric unit and crystal packing of the c-di-GMP-bound state is 
shown in Fig. 2.12A. In both, the nucleotide-free and c-di-GMP-bound crystals, the 
dimers A-B and C-D are formed via isologous contacts. The two equivalent, two-fold 
symmetric dimers (A-B and C-D) pack via a surface at the base of protomer A and C 
with an interfacial area of 519 Å2. Energetic calculations yield a positive value for the 
free energy gain for the interaction mediated by this interface, suggesting that it is not 
biologically relevant. There are no interactions between the REC domains of 
protomers A and B with protomer D, and between the REC domains of protomers B 
and C. Crystal packing interactions involving the HTH domains were not considered 
since they would interfere with DNA binding. 
Since the overall crystal packing contacts were preserved in the nucleotide-
bound structure, it suggests that c-di-GMP stabilizes one of the dimers that can form 
under certain conditions such as in the crystallization drop. In the c-di-GMP-bound 
structure, there are minor adjustments of the packing, especially with regard to the c-
di-GMP-mediated dimerization interface, but the protomers move as rigid bodies (Fig. 
2.12B and 2.12C). Superposition of protomers indicates a rigid conformation of VpsT 
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 with regard to the relative orientation of the REC and HTH domains (rmsd between 
0.5 and 0.9 Å over all atoms) independent of c-di-GMP binding, with a buried surface 
area between the domains of 1355 Å2, suggesting that such a conformation is unlikely 
to be due to crystal packing forces (Fig. 2.12B). 
The c-di-GMP-stabilized dimer discussed here consists of protomers A and B, 
while the nucleotide-independent dimer is formed by protomer A and a protomer B 
from an adjacent asymmetric unit. Equivalent interactions occur in the crystals 
between molecules C and D, and their symmetry mates. These interactions between 
protomers are propagated throughout the crystal lattice, suggesting that VpsT can 
form higher-order oligomers with two polymerization sites per dimer (Fig. 2.12A). 
The c-di-GMP-bridged protein interface has hydrophobic character and is 
largely stabilized by nucleotide binding to the base of α6 (Fig. 2.1C and 2.6B). An 
isoleucine residue at the center of the interface, located in α6, was mutated to 
glutamate in this study as a way to destabilize the formation of this dimer. A similar 
dimer involving α6 has been observed in the structure of a LuxR family two-
component response regulator from Aurantimonas sp. SI85-9A1 (PDB code 3cz5; 
Malashkevich et al.; unpublished) (Fig. 2.13A). In this case, phosphate and 
magnesium coordinating residues, as well as residues involved in the conformational 
switching, are similar to the response regulators PhoB and WspR suggesting that this 
REC domain is under control by phosphorylation (Fig. 2.13B). A bound phosphate 
ion at the putative phosphorylation site observed in the crystal structure supports this 
hypothesis. This response regulator lacks the VpsT c-di-GMP binding motif, but the 
structural resemblance and crystal packing contacts suggest a common mode for 
dimerization in this class of LuxR family response regulators, some of which appear 
to be regulated by ligand binding rather than phosphorylation. 
The constitutive, c-di-GMP-independent dimer interface contains polar 
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 interactions in addition to a hydrophobic groove at the bottom, a pocket 
accommodating the methionine residue crucial for formation of this dimer (M17; Fig. 
2.6A). In addition, the putative phosphorylation site (D60; Fig. 2.6A) is part of this 
interface, which may explain why expression of VpsTM17D, VpsTD60A or VpsTD60E in a 
∆vpsT strain affects motility and spot morphology in a similar manner (Fig. 2.10). 
While mutations in the putative phosphorylation site were designed to mimic a 
constitutively inactive (VpsTD60A) or a constitutively active (VpsTD60E) state, they had 
indistinguishable activities in gene expression and motility assays, suggesting that 
phosphorylation does not play a major role in the regulation of VpsT. 
Comparing the REC domain of VpsT to canonical REC domain-containing 
proteins such as PhoB, which are regulated by phosphorylation, suggests that VpsT 
employs a distinct mechanism (Fig. 2.13B). Many important residues for phospho-
induced switching in other REC domains are not conserved in VpsT. While the 
phopshorylation site and one of the magnesium-coordinating aspartates are present in 
VpsT (D60 and D14, respectively), it contains a serine-substitution in the position of 
the second magnesium-coordinating residue (S13) (Fig. 2.14). The lysine residue that 
usually forms a salt bridge with the phosphate moiety in canonical REC domains is 
replaced with an aspartate residue (D112). Only one of the switch residues is conserved 
(F109), whereas the crucial threonine residue in PhoB (or serine in some other REC 
proteins) is a cysteine in VpsT (C90). The switch residue F109 is involved in the 
conserved network of residues, and is engaged in a hydrophobic packing contact with 
the tryptophan residue of the c-di-GMP binding motif, possibly suggesting an 
allosteric path connecting the two dimer interfaces similar to that of canonical REC 
domains (Fig. 2.14B) (S15). 
While the dimer interfaces are predominantly hydrophobic, the DNA binding 
site is largely polar. To model the protein-DNA interaction we used an alignment with 
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 the HTH•DNA complex structure of NarL (PDB entry 1zg5) (S16), a response 
regulator, which shares 38% identity and a total of 85% sequence similarity with 
VpsT in its DNA-binding motif. Out of 24 residues participating in the formation of 
the protein-DNA interface in the NarL crystal structure (S17), 11 are identical and 10 
show conserved or semi-conserved substitutions in VpsT. Most of these residues lie in 
helix α10, buried in the large groove of DNA, while the rest are interspersed in helices 
α8, α9, and α11, as well as in the connecting loop regions.  Furthermore, all ten 
residues participating in direct hydrogen bond contacts with the DNA phosphate 
backbone or bases are conserved, with seven of them being identical between the two 
proteins. Substitutions were observed in two of the three residues forming hydrogen 
bonds with nucleobases in both VpsT and CsgD, presumably conferring specificity to 
the recognized DNA sequence (NarL-T183 is a serine in VpsT and CsgD; NarL-K192 is 
a histidine in VpsT and a tyrosine in CsgD). Thus, while consensus DNA motifs for 
NarL and CsgD binding have been proposed (S18-20), VpsT recognition sites remain 
to be experimentally determined. 
Based on this analysis, helix α10 was identified as a structural motif that binds 
to the major groove of DNA (Fig. 2.15). Considering the c-di-GMP-independent 
VpsT dimer, superpositioning of the HTH domains with a HTH•DNA complex 
structure of the homolog NarL suggests a binding mode in which the DNA is bent in a 
90°-angle, similar to that of transcriptional regulators such as the catabolite activator 
protein (S16, S21) (Fig. 2.15A). In contrast, the DNA molecules in the c-di-GMP-
mediated VpsT dimer model run anti-parallel to each other, a configuration that would 
introduce DNA loops (Fig. 2.15B). DNA looping has been described as a mode of 
action for λ repressor and as a mechanism for the regulation of the lac, gal and ara 
operons (S22, S23). Notably, while AraC binds multiple operator sites to stabilize 
DNA loops, the catabolite activator protein participates in the regulatory network of 
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 the ara operon, presumably by bending the DNA (S24). Based on its structure, VpsT 
would have the capacity to introduce both types of DNA deformations, bending and 
looping. 
Given that the distribution of VpsT binding sites on the Vibrio chromosomes 
remains unknown, we cannot rule out the possibility that both the c-di-GMP 
dependent and independent interfaces could serve a regulatory function on DNA, 
introducing distinct deformation upon binding. In DNA mobility shift studies, 
stronger binding to three of the four vpsL promoter fragments was observed with 
VpsTM17D, the mutant that cannot form the c-di-GMP-independent dimer, compared to 
wild-type VpsT (Fig. 2.2A). Although the c-di-GMP-independent dimer appears to 
affect DNA binding negatively for this particular promoter, its competence for DNA 
binding would depend on the distribution of VpsT recognition sequences across the V. 
cholerae genome. In addition to bending and looping DNA by dimeric VpsT, it would 
be feasible that VpsT forms higher order complexes on DNA upon c-di-GMP binding. 
A plausible tetramer, based on the VpsT crystal structure, would involve the c-di-
GMP-mediated dimerization of VpsT dimers (Fig. 2.15C). Alternatively, two c-di-
GMP-stabilized dimers could interact via the nucleotide independent interface. 
 
Oligomerization of VpsT in solution  
The dimeric, intercalated c-di-GMP conformation observed in the VpsT 
crystal structure has been also shown as prevalent under similar solution conditions 
(S25), and is hence unlikely to be due to crystal packing artifacts. Moreover, 
isothermal titration calorimetry (ITC) experiments revealed an apparent affinity for c-
di-GMP (~3 µM) with a 1:1 binding stoichiometry and large unfavorable change in 
enthropy (∆S ~ -34 kcal/mole). Consistent with potential cooperativity between 
nucleotide binding and VpsT dimerization through the corresponding interface, 
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 mutations destabilizing either interaction abolished c-di-GMP recognition (VpsTR134A, 
VpsTW131F, VpsTT133V and VpsTI141E, respectively; Fig. 2.7). Conversely, VpsT 
carrying a disruptive mutation in the alternative dimerization interface, VpsTM17D, 
bound c-di-GMP with similar to wild-type thermodynamic parameters (Fig. 2.7; Table 
2.S2). 
Elution of the nucleotide-free, wild-type VpsT showed a concentration-
dependent shift in the protein peak during analytical size exclusion chromatography 
(Fig. 2.8, box), indicating conversion between different oligomeric species. In 
addition, incubation with c-di-GMP caused the protein to fall out of solution unless 
the salt concentration was raised (up to 600 mM NaCl depending on protein 
concentration) or xylitol (5-10%) was present. Salt-stabilized, c-di-GMP-bound 
protein eluted in a yet distinct fractionation volume, consistent with oligomerization 
through both crystallographic interfaces. Analysis of wild-type VpsT by analytical 
ultracentrifugation corroborated c-di-GMP-dependent oligomerization, with trimers 
being observed at higher concentration (Fig. 2.9). A further increase in protein 
concentration increased the heterogeneity of the sample and the tendency for protein 
aggregation. 
In order to observe the differential effect of the two interfaces on c-di-GMP-
dependent regulation of VpsT in solution, we resorted to SEC-coupled static multi-
angle light scattering (MALS), a technique that reports the absolute molecular weight 
of macromolecules in any elution volume and independent of their shape (Fig. 2.8; 
Table S2). Experiments were conducted in high-salt buffer conditions (400-600mM 
NaCl) and at relatively high protein concentrations (~10 µg/µl or 400µM, injected 
concentration) in order to minimize c-di-GMP-driven polymerization and maximize 
association differences (see Fig. 2.8, box). While VpsTM17D in the absence of c-di-
GMP existed exclusively as a monomer, wild-type VpsT, VpsTR134A, and VpsTI141E 
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 exhibited molecular weights that were intermediate between those of a monomer and 
a dimer with relative concentration dependence throughout the elution peak. As 
reported for other systems (S26), such behavior is likely due to rapidly interchanging 
oligomeric species, with the constitutive, c-di-GMP-independent interface mediating 
sufficient dimerization on the SEC column. Cyclic di-GMP-mediated shifts to higher 
molecular weights were observed for VpsTM17D and wild-type VpsT, confirming a 
role for the second, c-di-GMP-dependent interface in signal-induced VpsT 
oligomerization. Shifts were more pronounced when c-di-GMP was included in the 
SEC buffer, compared to samples that were pre-incubated with c-di-GMP but 
analyzed in a mobile phase lacking the nucleotide (Fig. 2.8B-D, right column). As 
expected, mutants incapable of nucleotide recognition, VpsTR134A and VpsTI141E, 
showed no change in oligomerization state in the presence or absence of the 
nucleotide. 
Taken together, our solution data indicates a role for c-di-GMP in introducing 
a novel interaction interface in the VpsT quaternary structure. It is important to note 
that while cellular salt and protein concentrations might be significantly lower than 
the ones used in our in vitro studies, VpsT oligomerization in vivo would be facilitated 
by additional factors such as DNA binding, the architecture of available VpsT binding 
sequences on the Vibrio genome, and/or association with putative interacting partners 
among others. 
 
 Detailed analysis of the gene expression profiles  
Whole genome expression profiling comparison of a ∆vpsT strain harboring 
wild-type VpsT or VpsT point mutants (VpsTM17D, VpsTD60A, VpsTR134A or VpsTI141E) 
to that of cells harboring the pBAD vector allowed us to gain an insight into the 
complementation capacity of each clone. The overexpression levels were determined 
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 to be moderate, about 1.5-fold above the expression of vpsT in the rugose strain, 
according to qPCR (Fig. 2.16). 
Expression of wild-type vpsT led to the differential regulation of 54 genes (≥2-
fold change in expression, 3% FDR): 31 induced and 23 repressed, respectively. A 
complete list of differentially regulated genes is provided in Table 2.S3. Besides 
genes involved in biofilm matrix production, which are discussed in the main text, 
transcription of a set of genes, predicted to be in a three gene operon (VC1583: sodC, 
encoding superoxide dismutase, 1.7-fold change; VC1585: katB, encoding catalase; 
VC1584: ankB, protein of unknown function), is increased in the ∆vpsT strain 
harboring wild-type VpsT. This observation suggests that enhanced oxidative stress 
resistance in rugose variants and cells grown in biofilms are likely to be controlled in 
part by VpsT. 
VpsT with a mutation in either c-di-GMP binding (VpsTR134A, VpsTW131F, 
VpsTR133V or VpsTM17D/R134A) or the c-di-GMP-dependent dimerization interface 
(VpsTI141E) was unable to complement phenotypes associated with lack of vpsT (Fig. 
2.2 and 2.3; Fig. 2.11). In contrast, a VpsT version unable to undergo c-di-GMP-
independent dimerization (VpsTM17D) was able to complement and even over-
complement such phenotypes (Fig. 2.2). Expression the VpsTM17D led to the 
differential expression of 84 genes (≥2-fold change in expression, 3% FDR): 45 
induced and 39 repressed, respectively. A complete list of regulated genes is provided 
in Table 2.S3. For instance, expression of genes in the vps-I cluster were 2-fold 
greater in a ∆vpsT strain harboring VpsTM17D relative to that harboring wild-type 
VpsT. Similarly, expression of greater number of flagellar biogenesis genes was 
downregulated in the VpsTM17D-expressing ∆vpsT strain relative to that harboring 
wild-type VpsT. This result was confirmed by using a qPCR for transcript levels of 
flaA, one of the genes showing significant repression in the microarrays (Fig. 2.10A 
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 and B). Transcription of vpsR, cdgA (VCA0074), VCA0075, vpvA and vpvB, genes 
whose products positively regulate biofilm matrix production, were also higher in a 
∆vpsT strain harboring VpsTM17D. Taken together, our results suggest that c-di-GMP-
independent dimerization of VpsT could prevent DNA binding or contribute to the 
fine-tuning of the transcriptional response.  
                                                                                                                                           
Comparison with VpsT homologs and CsgD  
Vibrio parahaemolyticus, the causative agent of the most common Vibrio-
associated, seafood-borne gastroenteritis, utilizes VpsT and VpsR homologs to 
regulate capsular polysaccharide (Cps) production and biofilm formation (S27). 
However, the function of these proteins in Cps production differs significantly from 
their counterparts in V. cholerae.  For example, the VpsR homolog CpsR is not 
required for basal levels of cps expression but appears to induce cps gene expression 
in strains predicted to have elevated levels of c-di-GMP (S28, S29), which may 
indicate a similar, c-di-GMP-dependent regulation as has been described for FleQ 
(S30), a distant homolog of VpsR/CpsR in P. aeruginosa. The VpsT homolog in 
Vibrio parahaemolyticus, CpsS, negatively regulates cps transcription as cpsS deletion 
resulted in increased Cps production and super-rugose colony formation. Although the 
mechanisms by which CpsR and CpsS regulate cps transcription are yet to be 
determined, the presence of a VpsT-like c-di-GMP binding motif (W[F/L/M][T/S]R) 
in CpsS suggests that c-di-GMP may regulate CpsS function. 
As mentioned before, VpsT is homologous to the transcriptional regulator 
CsgD from E. coli and S. enterica serovar Typhimurium. CsgD is required for the 
production of the two major extracellular matrix components, exopolysaccharides and 
proteinaceous fimbriae (curli), leading to the development of a unique colony 
morphology characterized by extensive corrugation and biofilm formation (S31). As a 
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 consequence, E. coli and S. enterica mutants lacking CsgD produce flat and smooth 
colonies, similarly to V.cholerae mutants lacking VpsT (S32, S33). 
CsgD and VpsT share an overall similar architecture harboring a C-terminal 
LuxR type HTH domain and an N-terminal REC domain with homology to 
FixJ/LuxR family response regulators of two-component signal transduction systems. 
Similar to VpsT, the REC domain of CsgD contains the conserved aspartate residue 
(D59 in CsgD) predicted to be phosphorylated, but lacks crucial residues necessary for 
phosphotransfer. The mechanism by which CsgD gets activated is yet unknown. As 
discussed in the main text, the c-di-GMP binding motif is not conserved in CsgD, but 
other small molecules may bind to its receiver domain to regulate CsgD activity 
(S34). 
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 2.A2. Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Conservation of VpsT homologs in related Vibrio species. (A) 
Sequence alignment of VpsT homologs from various Vibrio species generated with 
ClustalW2 (S35) and formatted with ESPript (S36). Key residues responsible for c-di-
GMP binding, nucleotide-dependent, and constitutive dimerization are marked with 
closed arrows. Asterisks highlight residues directly involved in coordination of c-di-
GMP. Open arrows mark the degenerate phosphorylation switch, i.e. residues 
involved in magnesium coordination, phosphorylation, and phosphotransfer-
dependent conformational changes in canonical REC domains. The following 
sequences were used to generate the alignment: Vibrio cholerae O1 biovar El Tor str. 
N16961 (NP_233336), Vibrio parahaemolyticus 16 (ZP_05117817), Vibrio 
parahaemolyticus RIMD 2210633 (NP_800957), Vibrio harveyi ATCC BAA-1116 
(ABU73058), Vibrio fischeri ES114 (YP_205791), Vibrio shilonii AK1 
(ZP_01865459), Vibrio alginolyticus 12G01 (ZP_01258564), Vibrio sp. Ex25 
(ZP_04922131), Vibrio vulnificus YJ016 (NP_936438).  
(B) Sequence conservation mapped onto the solvent-accessible surface of VpsT. 
Conservation is presented as a color gradient from green to red (0%-100% 
conservation). Arrows and circles highlight structurally and functionally important 
motifs.  
(C) Surface conservation mapping based on alignment including VpsT-like protein 
sequences. As previously discussed, the latter carry a proline substitution at position 3 
of the c-di-GMP binding pocket (W[L/F/M]PR) (not shown in the alignment in A). 
The surface shows significantly less conservation, especially in the interaction 
interfaces suggesting subfamily-specific dimerization. 
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Figure 2.5: Cyclic di-GMP dependence of VpsT-mediated gene transcription. 
vpsL gene expression in different genetic backgrounds harboring a single-copy 
chromosomal vpsLp-lacZ fusion. Data are mean of 8 replicates -/+ SD. In this 
experiment, a smooth wild-type or vpsT-deletion strain was used that have low levels 
of c-di-GMP (S2). Induced expression of an active diguanlylate cyclase increases 
cellular c-di-GMP concentration (S2, S37). vpsL expression was driven to a large 
extent by VpsT in a c-di-GMP-dependent manner. A smaller fraction is independent 
of VpsT but requires an elevated c-di-GMP level. Although the analysis may be 
complicated by the usage of different genetic backgrounds, which may explain the 
differences in magnitude of vpsL expression comparing uninduced and induced 
samples, the data is supported by and consistent with other experiments described 
here that demonstrate that c-di-GMP and VpsT act in concert (Data courtesy of Jiunn 
C.N. Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
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Figure 2.6: Dimerization and nucleotide-binding interfaces.  
(A) The c-di-GMP-independent dimerization interface. A crystallographic dimer is 
shown in cartoon presentation (chain A-chain Bsym) (left). The close-up view shows 
the dimerization interface (right). Interfacial residues are shown as sticks and labeled 
appropriately, where A and asterisk (*) identify residues belonging to chain A and 
chain Bsym, respectively. Pair-wise interactions spanning the interface are also 
denoted. (B) c-di-GMP-dependent interactions. A crystallographic dimer formed by 
two protomers in one asymmetric unit (chain A-chain B) is shown in cartoon 
presentation (left). The interaction is mediated primarily through helices α6 of each 
chain and is stabilized by the coordination of an intercalated c-di-GMP dimer at the 
base. A close-up view shows the protein interface (top-right). The second close-up 
view shows the c-di-GMP binding pocket (bottom-right). Protein interface residues, 
as well as residues participating in electrostatic and π-stacking interactions with the 
nucleotide are depicted as sticks and appropriately labeled. Conservation of key 
residues participating in the formation of each interface is shown in the table at the 
bottom.  
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Figure 2.7: Isothermal titration calorimetry supports c-di-GMP binding in vitro. 
(A) Wild-type (wt) VpsT binds c-di-GMP with an apparent affinity in the low 
micromolar range (Kd ~ 3.2 µM). Binding occurs with a 1:1 stoichiometry in an 
entropically unfavorable (∆S ~ -34 kcal/mole) exothermic reaction (∆H ~ -1.7x104 
kcal/mole). The top panel shows baseline-corrected data collected at 20°C, while the 
bottom shows the results of curve-fitting using a single/independent site binding 
model.  
(B) Baseline corrected data collected at 20°C for the VpsTM17D, VpsTR134A, VpsTI141E, 
VpsTW131F, VpsTW131A, VpsTT133A and VpsTT133V mutants. While VpsTM17D 
complexes c-di-GMP with similar to wild-type affinity (Kd ~ 2.8 µM) and VpsTT133A 
with slightly reduced affinity (Kd ~ 7.4 µM), nucleotide binding was not detectable for 
the other VpsT mutants. 
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Figure 2.8: VpsT oligomerization state in solution.  
(A) Wild-type VpsT. The gel filtration profile of nucleotide-free, wild-type (wt) VpsT 
is characterized by a concentration-dependent shift in the elution peak (box). The 
protein concentration range is indicated as injected onto the column. SEC-coupled 
multi-angle light scattering analysis of wild-type VpsT in presence (middle) and 
absence (left) of c-di-GMP are shown. The signal from the 90°-scattering detector is 
shown in color, the signal from the refractive index detector is shown as dashed line 
and the UV absorbance is plotted in grey. Average molecular weights are plotted in 
black against the right Y-axis, as calculated every second across the protein elution 
peak. Theoretical molecular weights corresponding to those of a monomer and a 
dimer are indicated as horizontal dashed, grey lines. Rapid equilibria between 
monomers and dimeric assemblies are detected as species with intermediate molecular 
weights. Experiments evaluating the effects of c-di-GMP were conducted after pre-
incubation with excess nucleotide, followed by separation in a mobile phase lacking 
c-di-GMP. Injected protein and nucleotide concentrations were 400 µM and 600 µM, 
respectively.  
(B) VpsTM17D. The mutant was analyzed as described above. In addition, experiments 
were carried out with 40 µM c-di-GMP in running buffer (right) to stabilize the 
VpsT•c-di-GMP complex during SEC.  
(C) VpsTR134A. The mutant was analyzed as described in A and B. Asterisks denote 
small molecule peaks in the UV absorbance, plausibly due to the elution of unbound 
nucleotide.  
(D) VpsTI141E. The mutant was analyzed as described above. Results were similar to 
those obtained with VpsTR134A. Results from SEC-coupled multi-angle light scattering 
and ITC are summarized in Table S2. The monomeric molecular weight obtained with 
VpsTM17D compared to higher molecular weights for the rest of the mutants and the 
wild-type protein indicates constitutive VpsT dimerization through the nucleotide-
independent interface in the absence of nucleotide. Increased molecular weights and 
shifts in the elution peaks for the wild-type and M17D proteins in the presence of c-di-
GMP are indicative of a nucleotide-dependent change in oligomerization through the 
corresponding interface. 
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Figure 2.9: Analytical ultracentrifugation of wild-type VpsT. VpsT was analyzed 
by sedimentation velocity analytical ultracentrifugation at 8 and 12 µM protein 
concentration in the presence and absence of c-di-GMP (25 µM). Molecular weights 
were analyzed by using the program SedFit. 
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Figure 2.10: Functional analysis of VpsT with mutations at the putative 
phosphorylation site (Data courtesy of Jiunn C.N. Fong, Nicholas J. Shikuma, and 
Fitnat H. Yildiz).  
(A) Whole genome expression profiling. Top, compact heatmap in a log2-based 
pseudocolor scale (yellow, induced; blue, repressed) comparing differentially 
expressed genes in a ∆vpsT strain expressing wild-type (wt) or mutated VpsT versions 
compared to the vector control (midpanel, expression profiles of vps-I and vps-II 
clusters and genes encoding matrix proteins; bottom, expression profiles of flagellar 
biosynthesis genes)  
(B) Quantitative PCR for flaA expression. Expression of flaA in a vpsT-deletion strain 
(∆vpsT) expressing wild-type (wt) and mutant VpsT proteins from a pBAD plasmid. 
Concentration of the inducer arabinose is 0.1% as used in the β-galactosidase and 
expression profiling assays. Expression of the housekeeping gyrA gene is used for 
normalization. Data are mean of 3 replicates -/+ SD.  
(C) Motility phenotypes on semisolid LB agar plates. For strains expressing mutants 
of VpsT, single chromosomal insertion mutants are shown. The graph shows the mean 
migration zone diameter of each strain. Data are mean of 8 replicates -/+ SD.  
(D) Spot morphology. A wild-type rugose strain carrying the vector (pBAD) and 
∆vpsT strains carrying the vector or plasmids containing wild-type or mutant vpsT are 
shown (bars=1 mm). Mutations in the putative phosphorylation site designed to 
produce a constitutively inactive or active state, VpsTD60A and VpsTD60E, respectively, 
show identical phenotypes indicating that phosphorylation is unlikely a regulatory 
mechanism for VpsT function.  
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Figure 2.11: Spot morphology phenotypes for additional nucleotide binding 
mutants of VpsT. A wild-type rugose strain carrying the vector (pBAD) or a plasmid 
containing wild-type VpsT, and ∆vpsT strains carrying the vector or plasmids 
containing wild-type or mutant vpsT are shown (top, unscaled; bottom, scaled to 
similar diameter, bars=1 mm). The double VpsTM17D/R134A mutant shows a phenotype 
observed for the single VpsTR134A and VpsTI141E mutants, indicating that c-di-GMP-
driven dimerization is dominant in VpsT function. The boxed inset shows vpsL gene 
expression in different genetic backgrounds harboring a single-copy chromosomal 
vpsLp-lacZ fusion. Data are mean of 8 replicates -/+ SD (Data courtesy of Jiunn C.N. 
Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
. 
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Figure 2.12: Comparison of c-di-GMP-bound and nucleotide-free VpsT.  
(A) Asymmetric unit and crystal packing. The asymmetric unit contains four VpsT 
protomers (cartoon presentation), and is shown for the c-di-GMP-bound VpsT crystal. 
Adjacent symmetry mates are shown in transparent surface presentation illustrating 
the polymerization of VpsT in the crystals mediated by the c-di-GMP-stabilized and 
nucleotide-independent interfaces. Interfacial surface areas and interaction free energy 
gain estimations were calculated using the PISA server (S17).  
(B) Structural comparison of VpsT promoters. Superposition of the α-carbon 
backbone of all 8 symmetry-unrelated protomers in the unliganded and complex 
crystal structures of VpsT shows almost identical protein conformation (rmsd of 0.5-
0.9Å over all atoms).  
(C) Structural comparison of oligomeric assemblies of c-di-GMP-bound and 
nucleotide-free VpsT. Superposition of the corresponding crystallographic trimers 
using molecule A as the reference shows minor adjustments in the packing (top), 
where the VpsT protomers move as rigid bodies. A close-up view of the c-di-GMP 
binding site shows alternative rotamer conformation for arginine R134, as well as 
narrowing of the nucleotide-binding pocket in the apo-state (bottom). 
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Figure 2.13: Structure of a REC domain structurally related to VpsT.  
(A) Crystal structure of the receiver domain of a LuxR-like response regulator from 
Aurantimonas sp. SI85-9A1 (PDB code 3cz5; Malashkevich et al.; unpublished). A 
DALI search identified the aforementioned protein as a structural homolog to VpsT 
(S38). Similarly to VpsT, this receiver domain contains an additional helix α6, 
mediating dimerization contacts in the crystal lattice (top). However, no ligand is 
stabilizing the interaction, and a bound phosphate ion at the putative phosphorylation 
site (bottom) suggests control by phosphorylation. Residues involved in magnesium 
binding, phosphorylation, and phosphotransfer-dependent conformational changes are 
depicted as sticks and appropriately labeled. The phosphate ion bound at the putative 
phosphorylation site is shown as spheres.  
(B) Conservation of residues involved in phosphotransfer as compared to canonical 
(WspR and PhoB) and divergent (CsgD and VpsT) receiver domains. Residue 
numbers in the table correspond to the VpsT sequence. 
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Figure 2.14: Conserved residues form a path through the REC domain 
connecting the c-di-GMP-independent interface and the c-di-GMP binding site. 
(A) Structure of the receiver domain dimer showing c-di-GMP bound at the base of 
helices α6.  
(B) Close-up view of the putative phosphorylation site. Residues involved in 
phosphotransfer in canonical receiver domains are shown as sticks, as well as residue 
M17 from an adjacent molecule, stabilizing the constitutive dimer interface, and 
residue W131 from the c-di-GMP binding pocket (top). Conserved residues connecting 
the c-di-GMP-independent interface and the nucleotide binding site are shown in 
magenta. Interestingly, these include the degenerate phosphorylation site together 
with residues involved in phosphotransfer-related conformational switching, 
suggesting that they might form an allosteric path for phosphorylation-dependent α6 
dimerization in other LuxR-like response regulators (see Figure 2.13). 
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Figure 2.15: Models for DNA binding to VpsT.  
(A) Nucleotide-independent VpsT dimer. The dimer is shown in two views that are 
separated by a 45°-rotation along the x-axis. The structure of the HTH domain of 
NarL bound to cognate DNA (S16) was superimposed onto the HTH domain of VpsT 
to illustrate the DNA binding mode of VpsT dimers.  
(B) Cyclic di-GMP-stabilized VpsT dimer. The dimer is shown in two orthogonal 
views. DNA binding was modeled as described above.  
(C) Tetrameric models of VpsT•DNA complexes. Based on the crystal packing 
contacts, two plausible tetrameric assemblies can be constructed. In the left panel, c-
di-GMP bridges two nucleotide-independent dimers. The DNA was used from a 
structure of the catabolite activator protein, a transcriptional regulator that bends DNA 
in a 90°-angle (S21). In the right panel, two c-di-GMP-driven dimers associate via the 
nucleotide-independent dimerization interface of VpsT. The central DNA is taken 
from a catabolite activator protein•DNA complex structure, the lateral DNA 
fragments are taken from a NarL•DNA complex structure. The distribution of VpsT 
binding sites on the chromosomes is likely to determine the feasibility of these models 
for transcriptional regulation. 
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Figure 2.16: Quantitative PCR (qPCR) results show modest VpsT over-
expression. Expression of wild-type (wt) and mutant VpsT proteins from a pBAD 
plasmid introduced in a vpsT-deletion strain (∆vpsT) is compared to chromosome-
driven VpsT expression in the wild-type rugose strain carrying an insert-less vector. 
Concentration of the inducer arabinose is 0.1% as used in the β-galactosidase and 
expression profiling assays. Expression of the housekeeping gyrA gene is used for 
normalization. Data are mean of 3 replicates -/+ SD (Data courtesy of Jiunn C.N. 
Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
. 
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 2.A3. Supplemental tables 
Table S1: Data collection and refinement statistics 
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 Table S2: Oligomeric state and c-di-GMP binding affinity of VpsT 
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 Table S3: Gene expression profiles. Differentially expressed genes (≥2-fold) in 
rugose ∆vpsT harboring vpsT-WT, vpsT-M17D, vpsT-D60A, vpsT-R134A, or vpsT-I141E 
in comparison  to the same strain containing pBAD alone. Differentially expressed 
genes were determined using SAM software with criteria of a ≥2-fold change in gene 
expression and a false discovery rate of ≤3% (Data courtesy of Jiunn C.N. Fong, 
Nicholas J. Shikuma, and Fitnat H. Yildiz). 
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 (Data courtesy of Jiunn C.N. Fong, Nicholas J. Shikuma, and Fitnat H. Yildiz). 
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Table S4: Bacterial strains and plasmids 
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 2.A4. Material and Methods 
Bacterial strains, plasmids and culture conditions 
 The bacterial strains and plasmids used in this study are listed in Table 2.S4.  
All V. cholerae and E. coli strains were grown aerobically, at 30°C and 37°C, 
respectively.  Unless otherwise noted, growth medium consisted of Luria Bertani (LB) 
medium (1% Tryptone, 0.5% Yeast Extract, 0.5% NaCl, pH 7.5). LB-agar and LB-
soft agar contained 1.5% (wt/vol) and 0.3% (wt/vol) granulated agar (Difco), 
respectively. Concentrations of antibiotics used, where appropriate, were as follows: 
ampicillin (100 µg/ml), rifampicin (100 µg/ml), kanamycin (50 µg/ml), and 
chloramphenicol (5 µg/ml). 
 
Recombinant DNA techniques  
DNA manipulations were carried out using standard molecular techniques. 
VpsT point mutants were generated using QuikChange site-directed mutagenesis kit 
(Stratagene), following the manufacturer’s instructions. In-frame deletions and vpsLp-
lacZ single-copy chromosomal reporter strains were generated as described previously 
(S1-3). All point mutations and chromosomal deletions/insertions were sequence-
verified. 
 
Protein expression and purification  
The coding region corresponding to full-length VpsT from V. cholerae O1 El 
Tor (VCA0952) (S4) was amplified by standard PCR and cloned into a modified 
pET28a expression plasmid (Novagen) yielding N-terminally hexahistidine-tagged 
SUMO fusion proteins. The hexahistidine-tagged SUMO-moiety was cleavable using 
the protease Ulp-1 from S. cerevisiae.  
Native and selenomethionine-derivatized proteins were overexpressed in E. 
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 coli T7 Express or T7 Crystal Express cells, respectively (NEB). For the expression of 
native proteins, cells were grown in Terrific Broth (TB) media supplemented with 50 
µg/ml kanamycin at 37°C. At a cell optical density corresponding to an absorbance of 
0.8-1.0 at 600 nm (OD600), the temperature was reduced to 18°C, and protein 
production was induced with 1 mM IPTG. Selenomethionine-derivatized proteins 
were produced in cells grown in M9 minimal media supplemented with 50 µg/ml 
kanamycin, 1 µg/ml thiamine, 1 µg/ml biotin, 0.4% glucose and 40 µg/ml of each of 
the 20 amino acids with selenomethionine substituting for methionine. Protein 
expression was induced at OD600 of 0.4-0.5. After 16 hours, cells were harvested by 
centrifugation, resuspended in NiNTA buffer A (25 mM Tris-Cl, pH 7.5, 550 mM 
NaCl and 20 mM imidazole), and flash-frozen in liquid nitrogen. 
After cell lysis by sonication and removal of cell debris by centrifugation, 
clear lysates were loaded onto NiNTA columns (HisTrap; GE Healthcare) 
equilibrated in NiNTA buffer A. The resin was washed with 20 column volumes of 
NiNTA buffer A, and proteins were eluted in a single step of NiNTA buffer A 
supplemented with 500 mM imidazole. Proteins were buffer exchanged into desalting 
buffer (25 mM Tris-HCl, pH 7.5, 550 mM NaCl, 10mM imidazole, 5mM β-
mercaptoethanol), and affinity tags were removed by incubation with the yeast 
protease Ulp-1 at 4°C overnight. Cleaved proteins were collected in the flow-through 
during NiNTA affinity chromatography, and were subjected to size exclusion 
chromatography on a Superdex 200 column (GE Healthcare) equilibrated in gel 
filtration buffer (25 mM Tris-HCl, pH 7.5, 550 mM NaCl, 2mM DTT). Proteins were 
concentrated on a Centricon ultrafiltration device (10 kDa cutoff; Millipore) to a final 
concentration of approximately 1-4 mM. Protein aliquots were flash frozen in liquid 
nitrogen and stored at -80°C. 
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 Crystallization, data collection and structure determination  
Crystals were obtained by hanging drop vapor diffusion by mixing equal 
volumes of protein (10-40 mg/ml) and reservoir solution followed by incubation at 
20°C. For crystallization of the c-di-GMP bound state, protein incubated with c-di-
GMP was subjected to size exclusion chromatography for removal of unbound 
nucleotide prior to crystallization. The reservoir solution contained 0.1 M Tris-HCl 
pH 7.0, 0.8 M Potassium sodium tartrate tetrahydrate, 3-5% Polyethylene glycol 
monomethyl ether 5,000, and 8-12% xylitol. Crystals appeared within 3-10 days with 
typical dimensions of 0.40 mm x 0.08 mm x 0.08 mm. For cryo-protection, crystals 
were soaked in reservoir solution supplemented with 25% xylitol. Cryo-preserved 
crystals were flash-frozen and stored in liquid nitrogen. Data was collected on frozen 
crystals at 100 K using synchrotron radiation at the National Synchrotron Light 
Source (NSLS, Brookhaven National Laboratory, beamline X29). 
Data reduction was carried out with the software package XDS (S5). 
Experimental phases were obtained from multi-wavelength anomalous diffraction 
(MAD) experiments on crystals grown from selenomethionine-derivatized proteins. 
By using the software package HKL2MAP/Shelx (S6), 28 out of 32 heavy atom 
positions could be determined. Solvent flattening was carried out by using the 
program ShelxE (S6). The structure of c-di-GMP-bound VpsT was determined by 
molecular replacement using the software package PHENIX (S7) with the apo-
structure as the search model. Refinement in PHENIX (S7) and COOT (S8) yielded 
the final models. Data collection and refinement statistics are summarized in Table 
2.S1. Illustrations were made in Pymol (DeLano Scientific). 
 
Large-Scale Enzymatic production of c-di-GMP 
Large amounts of c-di-GMP were synthesized enzymatically using a highly 
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 active mutant of the diguanylate cyclase WspR and GTP as a substrate (S9). High 
purity of the compound was achieved by preparative reverse-phase HPLC followed by 
lyophilization. In a final step of the product analysis, it was enzymatically tested as a 
substrate for phosphodiesterases. Cyclic di-GMP concentration was determined based 
on absorbance at 254 nm in comparison with commercially obtained standard of 
known concentration (Biolog Life Science Institute). 
 
Size-exclusion chromatography (SEC)-coupled static multi-angle light scattering 
For SEC-coupled multi-angle light scattering, purified protein (~10 µg/µl or 
400 µM, injected concentration) was subjected to SEC using a Shodex KW-803 
column (JM Science, Inc.) equilibrated overnight in gel filtration buffer (25 mM Tris-
HCl pH 7.5, 400-600 mM NaCl, and 2 mM DTT). Where specified, wild-type or 
mutant VpsT was incubated with excess c-di-GMP for 30 minutes at room 
temperature prior to injection. In additional sets of experiments, c-di-GMP was also 
added to the gel filtration buffer at a concentration of 40 µM. The chromatography 
system was coupled to a 3-angle light scattering detector (miniDAWN TREOS) and a 
refractive index detector (Optilab rEX) (Wyatt Technology). Data were collected 
every second at a flow rate of 0.5 ml/min. Data analysis was carried out using the 
program ASTRA, yielding the molar mass and mass distribution (polydispersity) of 
the sample. For normalization of the light scattering detectors and data quality control, 
monomeric bovine serum albumin (BSA; Sigma) was used. 
 
Reverse-phase HPLC  
SEC eluted protein peaks from above were collected, concentrated to a final 
concentration of 10 µg/µl, heat denatured at 95°, and centrifuged at 14,000 rpm for 10 
minutes. Resulting supernatants were filtered through Microcon Centrifugal Filter 
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 Units (Millipore, 10 kDa cut-off) and separated on a C18 reverse-phase column using 
a methanol-phosphate gradient (buffer A: 100 mM potassium phosphate monobasic, 
pH 6.0; buffer B: 30% methanol/70% buffer A). Protein bound c-di-GMP was 
identified by comparison to a nucleotide standard. 
 
Analytical ultracentrifugation  
Sedimentation velocity experiments were carried out using an XL-I analytical 
ultracentrifuge (Beckman Coulter) equipped with an AN-60 Ti rotor. Proteins (8 and 
12 µM) were diluted in buffer (25 mM Tris-HCl pH 7.5, 550 mM NaCl, 2 mM DTT) 
in the absence or presence of c-di-GMP (25 µM), and were analyzed at a 
centrifugation speed of 130,000 x g. Data collection was carried out at 280 nm, 
followed by data analysis using the program SedFit (version 11.0). 
 
Isothermal titration calorimetry 
Apparent dissociation constants (Kd) and stoichiometry of interactions were 
measured by isothermal titration calorimetry (ITC) using a VP calorimeter (Microcal, 
Amherst, MA). Calorimetric titrations of c-di-GMP (250 µM in the syringe; 10 µl 
injections) and wild-type or mutant VpsT (25 µM in the cuvette) were carried out at 
20°C in assay buffer (25 mM Tris-HCl pH 7.5, 550 mM NaCl, 2mM DTT) with a 
spacing of 180 or 300 sec between injections. ITC data were analyzed by integrating 
heat effects normalized to the amount of injected protein and curve-fitting based on a 
single-site binding model using the Origin software package (Microcal). The 
dissociation constant was derived from the data by using standard procedures. 
 
RNA isolation 
V. cholerae cells were grown aerobically overnight in LB in the absence of 
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 arabinose. Cultures were diluted 1:500 in fresh media with the inducer arabinose 
(0.1%) and grown aerobically at 30°C with shaking at 200 rpm to an OD600 of 0.3 to 
0.4. Two ml aliquots of cultures were collected by centrifugation for 2 min at room 
temperature. Cell pellets were immediately resuspended in 1 ml Trizol reagent 
(Invitrogen) and stored at -80°C. Total RNA was isolated from the cell pellets 
according to the manufacturer’s instructions (Invitrogen). Contaminating DNA was 
removed by incubating RNA with RNase-free DNase I (Ambion), and an RNeasy 
Mini kit (Qiagen) was used to clean up RNA after DNase digestion. 
 
Quantitative PCR (qPCR) 
qPCR was performed as described previously (S3). Briefly, cDNA was 
synthesized from 1 µg of RNA from each sample using an iScript cDNA Synthesis 
Kit (Bio-Rad). The product was used as a template in a subsequent PCR reaction 
using Expand High Fidelity PCR System (Roche). PCR reaction conditions were as 
follows: 94°C for 2 min, then 25 cycles of 94°C for 30 sec, 55°C for 30 sec and 72°C 
for 30 sec, and a final 72°C for 2 min. Amplified products were analyzed on a 1.5% 
agarose gel and quantified using ImageQuant software (Molecular Dynamics). 
Intensities of each DNA band were normalized to the corresponding gyrA band. Three 
biological replicates were conducted for each treatment tested and reactions lacking 
reverse transcriptase were used as negative controls. 
 
Electromobility shift assays  
Electromobility shift assays (EMSAs) were performed using purified wild-
type or mutant VpsT proteins and DNA fragments tiling the vpsL promoter region. 
Briefly, biotinylated primers were used to amplify the corresponding chromosomal 
regions by standard PCR using genomic DNA as a template. Commercially available 
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 60 bp duplex biotin end-labeled Epstein-Barr Nuclear Antigen (EBNA) DNA (Pierce) 
was used as a negative control. Binding reactions contained final concentrations of 5 
nM labeled DNA, 1 µM protein, and 0.05 µg/µl Poly-dI-dC in the binding buffer (10 
mM Tris-HCl pH 7.5, 50 mM KCl, 75 mM NaCl, 10 mM MgCl2, 5% xylitol, 1 mM 
DTT, 0.1 mM EDTA). Where specified, c-di-GMP was added to a final concentration 
of 50 µM. After 40 min incubation at room temperature, DNA was resolved in 5% 
TBE-polyacrylamide gels (BioRad) with 0.5X TBE as running buffer (45 mM Tris 
Base, 45 mM Boric Acid, 1 mM EDTA). DNA mobility was visualized using 
LightShift Chemiluminescent EMSA kit (Pierce) following the manufacturer’s 
instructions.  
 
β-Galactosidase assays 
V. cholerae cells were grown aerobically overnight in LB in the absence of 
arabinose.  Cultures were diluted 1:500 in fresh media with the inducer arabinose 
(0.1%) and grown aerobically at 30°C with shaking at 200 rpm to an OD600 of 0.3 to 
0.4. β-galactosidase assays were carried out in MultiScreen 96-well microtiter plates 
fitted onto a MultiScreen filtration system (Millipore) using a previously published 
procedure (S10). The assays were repeated with two biological replicates and at least 
six technical replicates. 
 
Gene expression profiling 
Microarrays used in this study were performed as described previously (S3), 
except reference RNA was obtained from a ∆vpsT V. cholerae strain (Fy_Vc_4435) 
harboring pBAD/myc-His-B grown to mid-exponential phase (OD600 of 0.3 to 0.4) in 
LB with the inducer arabinose (0.1%), inoculated (1:500 dilution) with overnight 
grown culture. Differentially regulated genes were determined using three biological 
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 replicates and two technical replicates for each treatment (6 data points for each spot) 
with the SAM software (S11) using 2-fold differences in gene expression and 3% 
false discovery rate (FDR) as cut-off values. Microarray data has been deposited in 
the NCBI Gene Expression Omnibus (GEO) database. 
 
Spot morphology and motility assays 
Analysis of spot morphologies of strains carrying plasmids with either wild-
type VpsT or VpsT point mutants (VpsTM17D, VpsTR134A, or VpsTI141E) were carried 
out by spotting 2 µl of 1:200-diluted overnight cultures onto LB agar plates 
supplemented with 100 µg/ml ampicillin and 0.02% arabinose. Spot cultures were 
incubated for 1 day at 30°C and photographed. Spot morphologies shown are 
representation of two independent biological replicates. Motility assays were carried 
out with LB-soft agar (0.3% agar) inoculated from a single colony grown overnight 
on LB agar at 30°C. After incubation for 18 to 20 h at 30°C, the migration zone 
diameter was measured and compared between strains. 
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 APPENDIX  B 
 
 
Additional targets and future directions 
 
2.B1. Identification of VpsT consensus binding sites in promoter/enhancer DNA 
The global effects of c-di-GMP mediated signaling, where distinct responses 
affecting motility, secretion, and biofilm formation are concertedly tuned to rapidly 
adapt bacteria's physiology and virulence potential (B1), make regulators of gene 
expression likely candidates for c-di-GMP responsive effectors. Such addaptational 
strategy was recently confirmed in the literature by the identification of protein 
transcription factors (FleQ of P. aeruginosa, Clp of X. campestris), as well as a 
riboswitch class in some messenger RNAs, to directly sense c-di-GMP and regulate 
gene expression at the transcription initiation and post-transcriptional levels, 
respectively (B2-B5). Here, we presented the crystal structure of Vibrio cholerae 
VpsT and identified it as a yet another transcription regulator which inversely controls 
biofilm formation and motility in response to fluctuations in intracellular c-di-GMP. 
In rugose cells, VpsT positively regulates and shares an overall similar regulon 
with VpsR, a transcription factor homologous to c-di-GMP sensing FleQ of 
Pseudomonas aeruginosa (B6-B9). Bioinformatic analysis of the upstream non-coding 
regions of genes that are differentially expressed between the rugose (R) variant and 
an R∆vpsR strain, has led to the identification of a highly significant palindrome 
motif, later confirmed experimentally to directly bind VpsR (B10, B11). Since VpsR 
and VpsT regulate by and large the same set of genes (B8), similar bioinformatic 
approaches have failed to distinguish between binding sites for the two proteins, 
assuming that they are non-overlapping. The potential for hierarchical gene 
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 regulation, where VpsT acts indirectly by stimulating or repressing the expression of 
other transcriptional regulators, including VpsR, further complicates such analyses.  
As discussed in the previous section, the DNA binding domain of VpsT shares 
high percent sequence similarity with the helix-turn-helix motifs of NarL and CsgD 
(Fig. 2.17) (B9). However, most of the conserved residues participate in protein-DNA 
interactions through the DNA phosphate backbone, contributing little or no sequence 
specificity (B12). Thus, while consensus DNA motifs for CsgD and NarL binding 
have been previously proposed, VpsT recognition sites remain to be experimentally 
determined (B13-B15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17: Structural basis for sequence specificity.  
(A) Structural alignment of the DNA-binding domain of VpsT (slate, pdb entry: 3klo), 
the modeled DNA-binding domain of CsgD (orange, Swiss Model), and the DNA-
binding domain of NarL bound to its cognate DNA (wheat and olive, pdb entry: 
1zg5). Lys192 is one of the few NarL residues participating in direct hydrogen 
bonding with DNA nucleobases (B12, B15). While it fits in the large groove of DNA 
to stabilize the protein-DNA complex, corresponding residues in VpsT and CsgD are 
divergent and sterically incompatible. 
 (B) Alignment of the DNA-binding modules of the three proteins (B9). Residues 
participating in direct contacts with nucleobases are marked with green symbols. 
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 In order to establish the specific DNA sequences responsible for VpsT-
mediated gene regulation a number of sophisticated approaches can be employed. For 
the selection of high-affinity DNA motifs that would be later suitable for 
crystallographic studies, Systematic Evolution of Ligands by EXponential enrichment 
(SELEX or in vitro selection) is a primary method of choice (B16, B17). Briefly, a 
double stranded DNA library of oligonucleotides, harboring a central random region 
(30-40 base pairs) flanked by tails of fixed sequence to be used for PCR amplification 
and sequencing, would be subjected to VpsT affinity chromatography. To this end, 
VpsT expressed either as an N-terminal hexahistidine SUMO fusion protein (His6-
SUMO-VpsT) or as a C-terminally tagged VpsT-MYC-His6 construct is shown to 
remain functional and can bind c-di-GMP in vivo (data not shown). In vitro bound 
oligonucleotides will be eluted, amplified, sequenced, and subjected to subsequent 
rounds of selection with increasing stringency of the binding conditions. In order to 
determine possible conformation-specific binding sequences, in vitro selection 
experiments with wild-type VpsT and VpsT point mutants of choice must be 
performed in parallel and in the presence or absence of nucleotide. 
 Although a powerful approach, oftentimes stringent in vitro selection yields 
sequences with much higher binding affinity and significant sequence divergence as 
compared to naturally occurring consensus motifs. In fact, transcriptional regulation 
in the cell often involves cooperative binding of multiple factors, that have otherwise 
weak affinities for their cognate DNA recognition sites (B18-B21). To overcome this, 
alternative or complementary to SELEX are Chromatin Immuno-Precipitation  (ChIP) 
approaches (B22-B24). Briefly, V.cholerae strains expressing functionally tagged 
wild-type VpsT or VpsT point mutants would be grown under conditions favoring 
expression of biofilm determinants. Harvested cells would be subjected to mild 
formaldehyde crosslinking conditions to stabilize protein-DNA complexes. Following 
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 cell lysis and fragmentation of DNA, VpsT-DNA complexes would be 
immunoprecipitated by using standard affinity purification protocols. After reversal of 
the crosslinks, protein-bound DNA would be purified and subjected to low-cost next-
generation sequencing for identification of consensus binding motifs.  
 Finally, a more targeted approach for identification of VpsT-specific DNA 
motifs would involve DNase I footprinting approaches (B25, B26). In our promoter-
binding studies we showed that VpsT binds in a c-di-GMP dependent manner to 
multiple sites in the VpsL promoter region, without the requirement of additional 
factors for complex formation (B6). In addition, we have established protocols for the 
expression and purification of several VpsR constructs, the highly conserved core 
RNA Polymerase of E.coli, and σ-factors of V.cholerae likely involved in promoter 
recognition and transcription initiation (Fig. 2.18). By using DNase I footprinting as 
an analytical tool, the characterization of protein protected DNA motifs in different 
binding reactions would help to identify not only the VpsT-specific DNA recognition 
sequence, but also potential cooperativity in factor binding, σ-factor specificity, and 
repositioning of complex components en route to transcription initiation.  
 
 
 
 
 
 
 
 
Figure 2.18: Purified VpsR, σ-factors, and core RNA Polymerase. Proteins were 
expressed in E.coli BL21 cells and purified through NiNTA affinity chromatography. 
RpoS and RpoD σ-factors, as well as the VpsR construct were cloned out of genomic 
Vibrio cholerae DNA. Core RNA Polymerase was derived from Escherichia coli and 
shares almost complete sequence identity with its Vibrio cholerae homolog (B9). 
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 2.B2. Determining the structure of c-di-GMP•VpsT•DNA complexes 
 We have presented here the crystal structures of VpsT in its nucleotide-free 
and c-di-GMP bound states (B6). As discussed in the previous section, the two 
structures are almost identical apart from a small rigid body displacement and minor 
side chain rearrangements in the nucleotide-binding pocket. The near-perfect 
superposition of the symmetry-unrelated protomers and the large area of buried 
surface at the interdomain interface, indicate that the observed relative orientation of 
the two domains is likely preserved in solution, especially considering the high 
percent (67%) solvent content in the VpsT crystals (B27, B28).  
 Identification of minimal DNA sequences capable of high affinity binding to 
apo-VpsT or c-di-GMP•VpsT is crucial for pursuing the structural determination of 
protein-DNA complexes in crystallographic studies. Oligonucleotides selected in 
high-stringency in vitro selection would be used in crystallization trials with 
commercially available sparse-matrix screens and following established protocols. In 
addition, Small Angle X-ray Scattering (SAXS) can be used as an in-solution 
approach for the determination of low-resolution structural models. SAXS-derived 
distance distribution functions, molecular weights, and ab initio envelope models 
provide a fast and powerful tool to explore the assembly states and domain-domain 
orientation of proteins and nucleoprotein complexes, sensitive to detect even subtle 
conformational changes or multiple conformations in solution (B29-B31).  
 Based on the relative orientation of the DNA-binding domains of VpsT in the 
crystal structures, we hypothesize that its regulatory function on DNA leads to major 
changes in DNA architecture, such as DNA bending and/or looping upon promoter 
binding and nucleotide recognition (B6). The fact that nucleotide-bound VpsT 
recognizes multiple and relatively remote regions in its cognate vpsL promoter is also 
consistent with such a hypothesis. Both modes of DNA deformations have been 
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 previously described as regulatory modes in modulating bacterial gene expression 
(B32-B35). Looping has been established as the primary mode of action for the λ 
repressor and AraC, whereas proteins such as the catabolite activator protein are 
shown to introduce a 90° bend in the DNA helix upon protein-DNA complex 
formation. To test our hypothesis and reveal structural changes in DNA upon VpsT 
engagement, negative-stain electron microscopy would be a primary method of choice 
to directly image the structure of naked and c-di-GMP•VpsT-bound DNA (B36, B37). 
Briefly, samples would be spotted onto poly-lysine-coated carbon-formvar grids and 
negatively stained with uranyl acetate. Wild-type VpsT and VpsT point mutants 
characterized by different oligomerization potential would be used in parallel 
preparations. If necessary, DNA-bound VpsT can be further visualized by gold 
immunolabeling or similar enhancing approaches (B38).  
As an alternative approach to electron microscopy, atomic force microscopy 
(AFM) can be used to directly visualize protein-induced changes in DNA architecture 
(B39, B40). Advantages of the technique include the ease of sample preparation, 
where mica sample carriers require only a positively charged coating (polylysine or 
poly-L-ornithine), and no subsequent sample staining or enhancement. As recently 
shown for similar protein-promoter DNA systems (B41), the inherent high resolution 
and three-dimensional information that the method provides could also serve to 
directly derive the oligomeric state of DNA-bound VpsT protein variants.  
 
2.B3. Structure-function analyses of V. cholerae VpsR and P. aeruginosa FleQ 
 As mentioned above, VpsT functions in concert with VpsR, an AAA+ 
domain-containing protein similar in sequence and domain organization to the c-di-
GMP dependent transcription factor FleQ of Pseudomonas aeruginosa. The two 
proteins contain a relatively divergent N-terminal response receiver domain, followed 
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 by more conserved AAA+ σ54-interaction domain and a C-terminal helic-turn-helix 
DNA-binding motif (B42, B43).  
 When bound to DNA, FleQ acts as a master activator of flagellar gene 
expression, as well as a repressor of the pel exopolysaccharide synthesis operon (B44, 
B2). C-di-GMP binding to the protein is an "off" switch for DNA binding and thus 
leads to motility inhibition and biofilm formation. Nucleotide recognition is shown to 
occur independently of the N-terminal receiver domain, but other than that nothing is 
known about the mode of interaction (B2). Unlike VpsR, FleQ of Pseudomonas 
aeruginosa appears to function independently of a VspT protein homolog.  
 Similarly to the function of VpsT in vivo, gene expression under the control of 
VpsR appears dependent on a c-di-GMP signaling input (B45). Whether VpsR, like 
FleQ,  is on itself a c-di-GMP sensing effector, or VpsT function suffices to relay the 
second messenger's signal remains to be experimentally determined. While the former 
scenario would identify VpsR as a novel c-di-GMP receptor, the latter would suggest 
direct interaction between the two proteins, which would likely occur in a c-di-GMP 
dependent manner.  
 To this end, we have expressed full-length FleQ as well as truncated FleQ and 
VpsR constructs lacking the divergent N-terminal receiver domains (Fig. 2.18 and 
Fig. 2.19). As a positive control, we confirmed that FleQ binds c-di-GMP, and that 
binding is independent of the N-terminal receiver domain. An established SEC/HPLC 
coupled chromatography assay and/or ITC would be useful to determine binding of c-
di-GMP to VpsR. Crystallographic trials using commercially available sparse-matrix 
screens would be used in attempts toward crystallization and structure solving.  
 To date, we have identified preliminary conditions for the crystalization of 
truncated FleQ (137-477) (Fig. 2.18) The native protein crystallizes in the presence of 
c-di-GMP in a P6322 space group (Fig. 2.18B). The crystals are characterized by 
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 extremely high solvent content (79%), resulting in suboptimal anisotropic diffraction. 
Experimental phases were obtained by Single-wavelength Anomalous Diffraction 
(SAD) experiments on crystals grown from selenomethionine-derivatized protein 
(data not shown). Further model building, refinement, and functional assays would be 
necessary to determine biologically significant interfaces, residues participating in c-
di-GMP coordination, and the ligand's effects on FleQ structure and function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.19: Expression, purification and preliminary structural studies on FleQ 
of Pseudomonas aeruginosa.  
(A) Domain diagram of full-length (FL) and truncated (T) FleQ with preserved 
functions in c-di-GMP sensing and DNA recognition. The linker region between the 
AAA+ σ-54 interacting domain and the helix-turn-helix motif contains a conserved 
RXXD motif. As shown by us and others, similar motifs serve as allosteric c-di-GMP 
binding sites in active diguanylate cyclases or divergent homologs.  
(B) Preliminary structural studies: Expression, crystalization and data collection 
statistics.  
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 2.B4. Detection of putative VpsT-VpsR interactions.  
 The way VpsT and VpsR work together and with the core transcriptional 
machinery in the cell remains largely unknown. One possibility, supported by the fact 
that the two proteins regulate mostly the same sets of genes  in vivo, is that VpsT and 
VpsR directly interact to translate the c-di-GMP message in controlled expression of 
biofilm determinants.  
Surprisingly, analysis of the R∆vpsT, R∆vpsR, and R∆vpsT∆vpsR mutants 
(gene knockouts in the rugose morphotype) has suggested that the two proteins have 
distinct roles in determining biofilm architecture (B8). All three deletions cause 
rugose to smooth colony conversion, and the R∆vpsR and R∆vpsT∆vpsR mutants 
develop identically, with only small microcolonies or single cells attached to the 
substratum. In contrast, under certain growth conditions R∆vpsT can develop well-
differentiated biofilms and the magnitude of the deletion effects on gene expression is 
by and large lower than that for the R∆vpsR or R∆vpsT∆vpsR mutants (B8). This 
presents several possible scenarios for the regulation of the VpsT/VpsR system. It is 
plausible that VpsR is essential and sufficient for biofilm formation, has c-di-GMP 
binding capacity similar to that of FleQ in Pseudomonas aeruginosa (B2), but utilizes 
VpsT as an activity enhancing partner through direct or indirect protein interactions. 
Alternatively, VpsR could be sufficient for the basal transcription of biofilm 
determinants but would require VpsT to inhibit motility and boost biofilm formation 
as a response to elevated c-di-GMP levels. As discussed in the previous chapter, the 
Vibrio cholerae genome encodes for an additional VpsT/CsgD-like protein, VC0396, 
which might compensate for some of the VpsT functions in the R∆vpsT background. 
VC0396 contains a conserved WLPR motif at the putative c-di-GMP binding site 
(B42), which is a sequence capable of c-di-GMP recognition when introduced in the 
nucleotide-binding pocket of Vibrio cholerae VpsT (data not shown).  
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  To test for putative VpsT-VpsR interactions, a variety of in vitro or cell-based 
assays could be employed. Pull-down experiments, using differentially tagged 
purified proteins, or gel filtration and gradient co-sedimentation experiments with tag-
free protein constructs, are among the various available in vitro approaches. Similar 
isolated systems present the opportunity to screen for a variety of binding conditions, 
such as the absence or presence of c-di-GMP and the differential dimerization of 
VpsT  by the use of appropriate interface mutants. It is possible however that the 
native formation of a VpsT/VpsR complex is further controlled by post-translational 
modifications, small molecule binding, or cooperative interactions in higher-order 
protein or protein-DNA complexes. In addition, purification of heterologously 
expressed full-length VpsR has proved challenging (data not shown), indicating that 
the protein might need additional cellular factors for stability. To account for this, 
differentially tagged VpsT and VpsR can be expressed from vectors allowing 
inducible heterologous co-expression for in situ complex formation. Alternatively, 
functional vpsT- and vpsR-tag fusions can be introduced in the genome of the 
R∆vpsT∆vpsR Vibrio mutant to allow for protein expression under the control of 
native promoters at the genes' original locations. In situ complex formation can then 
be detected by metal affinity pull-downs or co-immunoprecipitation depending on the 
used protein-tag fusions. The latter approach would also provide the opportunity to 
screen for VpsT/VpsR complex formation at different growth conditions or 
developmental stages and, if coupled to mass-spectroscopic analysis, to identify 
additional binding partners for the two master regulators of biofilm formation.  
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 CHAPTER  3 
 
 
Preface 
 
Pseudomonas fluorescens, an important biocontrol microorganism, provides 
an attractive system to study bacterial biofilm formation. While its ability to form 
homobiofilms indicates that all components necessary for this signaling process are 
encoded in its own genome, key proteins involved in the different stages of bacterial 
attachment, macrocolony formation and biofilm dispersal have been recently 
identified.  
In the following work, a collaborative effort between the Sondermann Lab at 
Cornell University and the O’Toole Lab at Dartmouth Medical School, we provide a 
complete mechanistic description for c-di-GMP mediated inside-out signaling, a novel 
paradigm in bacterial signal transduction. Cytoplasmic c-di-GMP levels, sensitive to 
environmental substrate availability, are sensed by a transmembrane receptor relaying 
the signal to a periplasmic effector partner, whose proteolytic activity determines 
biofilm initiation and dispersal. Such level of resolution, elucidating an entire c-di-
GMP-mediated control circuit, from environmental signal to molecular output, is 
unprecedented for any other c-di-GMP pathway in the current literature.  
 
 
 108
 Structural basis for c-di-GMP-mediated inside-out signaling controlling 
periplasmic proteolysis * 
 
3.1. Abstract 
The bacterial second messenger c-di-GMP has emerged as a central regulator 
for biofilm formation. Increased cellular c-di-GMP levels lead to stable cell 
attachment, which in P. fluorescens requires the widely conserved, transmembrane 
receptor LapD. Cyclic di-GMP binding to its degenerate phosphodiesterase domain is 
communicated via a HAMP relay to the periplasmic domain, triggering a 
sequestration of the protease LapG, thus preventing cleavage of the surface adhesin 
LapA. Here, we elucidate the mechanism of autoinhibition and activation of LapD. In 
the absence of c-di-GMP, the intracellular module is held in an inactive state that is 
disrupted by c-di-GMP binding. The active state involves dimerization of c-di-GMP-
bound phosphodiesterase domains via conserved interactions found in c-di-GMP-
degrading enzymes. Efficient mechanical coupling of the conformational changes 
across the membrane is realized through an extensively domain-swapped periplasmic 
fold. Our analyses identified a conserved system for the regulation of periplasmic 
proteases, common in many free-living and pathogenic species. 
 
_____________________________________________________________________ 
* Reproduced from [Marcos V.A.S. Navarro ¶, Peter D. Newell ¶, Petya V. Krasteva ¶, 
Debashree Chatterjee ¶, George A. O’Toole, and Holger Sondermann (submitted)]  
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M.V.A.S.N., P.V.K., D.C., P.D.N., G.A.O. and H.S. designed research; M.V.A.S.N., 
P.V.K., D.C., and P.D.N. performed research; M.V.A.S.N., P.V.K., D.C., P.D.N., 
G.A.O. and H.S. analyzed data; and P.V.K. and H.S. wrote the manuscript. 
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 3.2 Introduction 
Bacterial biofilms arise from planktonic microbial cells that attach to surfaces 
and form sessile multicellular communities, relevant for survival in hostile habitats 
and for bacterial pathogenesis (1). Recent work has identified biofilm formation as a 
multiphase process with strict temporal and spatial regulation, often accompanied by 
adaptational strategies such as phenotypic variation, development of antibiotic 
resistance, and virulence gene expression (2, 3). On the cellular level, functional 
differentiation including changes in motility, cell adhesion, and secretion are among 
the many processes driving bacterial biofilm formation. Such a plethora of 
physiological responses inevitably begs the question of how regulation is achieved, 
and a nucleotide unique to bacteria, cyclic dimeric GMP (c-di-GMP), has emerged as 
a key signaling molecule in this process (4, 5) 
Cyclic di-GMP is a monocyclic RNA dinucleotide that functions as an 
intracellular second messenger exerting control at the transcriptional, translational, 
and posttranslational levels (6). It is generated from two GTP molecules by GGDEF 
domain-containing diguanylate cyclases, and degraded by phosphodiesterases (PDEs) 
containing either EAL or HD-GYP protein domains (7-10). Once generated, c-di-
GMP is believed to act in a protein-bound form, eliciting localized, rather than more 
general, diffusive signals (5). To date, few but strikingly diverse c-di-GMP receptors 
have been identified. Protein domains involved in c-di-GMP signal recognition 
include PilZ domains (11, 12), a non-canonical receiver domain in VpsT of Vibrio 
cholerae (13), the AAA σ54 interaction domain-containing transcription factor FleQ 
of Pseudomonas aeruginosa (14), and the cyclic nucleotide monophosphate-binding 
domain in Clp of Xanthomonas campestris (15). In other cases, c-di-GMP turnover 
domains can also serve as sensors for the nucleotide. For example, in GGDEF 
domain-containing proteins, an RxxD motif can serve as a c-di-GMP-binding 
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 inhibitory site to regulate either the activity of active enzymes (e.g. PleD of 
Caulobacter crescentus, WspR of Pseudomonas aeruginosa) (16, 17), or to mediate 
protein-protein interactions in degenerate homologs (e.g. PelD of Pseudomonas 
aeruginosa, CdgG of Vibrio cholerae) (18,19). 
Proteins participating in c-di-GMP-mediated signal transduction are often 
composed of multiple domains, allowing for a variety of regulatory inputs, signal 
ramifications and/or physiological responses (20). For example, a large number of 
bacterial proteins contain both, GGDEF and EAL domains in the same polypeptide 
chain. These proteins fall into three main categories based on their catalytic activity: 
Tandem domain-containing proteins with both, diguanylate cyclase and 
phosphodiesterase activity; proteins with only one active domain, in which the 
degenerate, inactive domain serves a regulatory function; and proteins in which both 
domains are degenerate, likely to work as c-di-GMP receptors (21, 22). Despite the 
vast abundance of this signaling module, structural and mechanistic insight regarding 
their function and regulation is sparse. 
The transmembrane protein LapD belongs to the last group, containing 
degenerate GGDEF and EAL domains that lack catalytic activity, but capable of c-di-
GMP binding via its divergent phosphodiesterase domain (23). LapD is required for 
stable cell attachment and biofilm formation in Pseudomonas fluorescens and 
Pseudomonas putida (24-26), where it controls the localization of the cell surface 
adhesin LapA in a c-di-GMP-dependent manner (23, 26). Binding of c-di-GMP to the 
LapD EAL domain is relayed to the periplasmic output domain through an inside-out 
signaling mechanism that utilizes a juxtamembrane HAMP domain, a relay module 
often found in bacterial transmembrane receptors. As a result, the amount and stability 
of LapA at the cell surface is increased, leading to stable cell attachment and biofilm 
formation (23). 
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 Recent work by Newell et al. reveals the complete c-di-GMP signaling circuit 
by which LapD controls cell attachment in response to phosphate availability (27). 
For wild-type LapD, c-di-GMP binding appears to induce a conformational change, 
which activates the receptor. As a consequence, the affinity of the periplasmic domain 
towards the cysteine protease LapG increases, limiting its access to LapA. 
Perturbations in the HAMP domain by deletion of some key elements yield a 
constitutively active receptor, independent of nucleotide binding. However, what 
prevents LapD from adopting an active conformation and how nucleotide binding 
translates into an output signal has remained unknown. 
Here, we elucidate the autoinhibition and activation mechanism of the c-di-
GMP receptor LapD from Pseudomonas fluorescens. The crystal structure of the 
cytoplasmic module containing the GGDEF-EAL tandem domains reveals the 
presence of an autoinhibitory latch formed by a helical extension of the HAMP 
domain. In this inactive state, the GGDEF domain functions as a lid restricting 
nucleotide access to the EAL domain module. The crystal structure of dimeric 
nucleotide-bound EAL domains provides insight in the conformational changes 
resulting from c-di-GMP binding. Based on the crystal structure of the periplasmic 
output domain of LapD, we identify functionally important residues and propose a 
model for the regulation of its activity in inside-out signal transduction. Finally, our 
structural studies highlight many conserved features that allowed us to identify similar 
signaling systems in a variety of bacterial strains including common pathogens such 
as Vibrio cholerae and Legionella pneumophila. 
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 2.3. Results and Discussion 
Autoinhibition of the intracellular module of LapD in the off-state 
In order to elucidate the molecular mechanism that regulates LapD function, 
we determined the crystal structure of the intracellular module of P. fluorescens 
LapD, comprising a HAMP-GGDEF domain linker segment and the degenerate 
GGDEF-EAL domain module (LapDdual; residues 220-648) (Fig. 3.1). Based on 
secondary structure predictions, the linker forms a continuation of the second HAMP 
domain helix (Fig. 3.8). We will refer to this motif as the signaling or S helix in 
analogy to helical extensions found in association with other HAMP domains, where 
they are involved in transducing signals through the HAMP domain to the adjacent 
signaling modules (28-30). 
LapDdual was purified to homogeneity by standard chromatography. Crystals 
were obtained by hanging drop vapor diffusion (space group P32; one molecule in the 
asymmetric unit). Selenomethione-substituted protein crystals diffracted X-rays to 2.5 
Å (Table S1). The structure was solved by single-wavelength anomalous dispersion 
(SAD) phasing, and initial phases were extended to higher resolution obtained from 
native protein crystals. The model was built into the experimentally phased map and 
further refined at 2.0 Å resolution. We also obtained a second crystal form involving 
different crystal packing contacts (space group I23, one molecule in the asymmetric 
unit), yet the overall conformation of LapD in the two crystals is identical (rmsd of 
0.9 Å over all atoms; Fig. 3.9A). In both cases, the biologically significant unit was 
predicted to be a monomer based on energetic and geometric estimations (31). In 
addition, we solved the structure of the isolated EAL domain of LapD bound to c-di-
GMP in two different crystal forms (residues 399-648; LapDEAL•c-di-GMP; Fig. 
3.9B), which will be discussed below. 
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 LapDdual adopts a compact, bilobal conformation (Fig. 3.1A). The GGDEF 
domain, comprising the N-terminal lobe, caps the nucleotide-binding pocket of the 
EAL domain, which presents the C-terminal lobe of the tandem-domain structure. The 
EAL domain buttresses the N-terminal S helix via predominantly hydrophobic 
interactions, burying 1170 Å2 (Fig. 3.1). The binding groove on the EAL domain, 
which accommodates the S helix, consists of the helix α10 and an adjacent loop. The 
latter has been identified as a conserved motif in catalytically active EAL domain-
containing phosphodiesterases, in which it is involved in dimerization, substrate 
specificity and metal ion coordination in the active site (32, 33). This loop was 
referred to as loop 6 in SadR/RocR and β5-α5 loop in the light-regulated 
phosphodiesterase BlrP1. In an attempt to introduce a more general nomenclature, we 
will refer to this motif as the switch loop. 
In addition to the S helix-EAL domain interaction, the GGDEF domain 
contacts the nucleotide-binding surface of the EAL domain at multiple points, 
forming a loosely packed interface that buries 1620 Å2 of surface area (Fig. 3.1A; Fig. 
3.10A and 3.10B). One such contact, the salt bridge between an arginine residue 
(R450), located just downstream of the signature EAL motif (KVL in LapD) at the 
center of the c-di-GMP-binding site, and a glutamate residue (E262), presented by a 
loop of the GGDEF domain (“lip”), forms a particularly close interaction 
incompatible with c-di-GMP binding (Fig. 3.10A and 3.10B). Although apo-LapD is 
in a c-di-GMP-binding incompetent state, the binding site is not completely occluded 
and may allow for competing out the inhibitory interactions by c-di-GMP (Fig. 
3.10B). 
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Figure 3.1: Autoinhibited structure of the cytoplasmic domain of LapD (Data 
courtesy of Marcos V.A.S. Navarro). 
(A) Crystal structure of apo-LapDdual. The domain organization of LapD from P. 
fluorescens Pf0-1 is shown. The degenerate sequence of the GGDEF and EAL 
signature motifs are indicated. The crystal structure of the LapDdual (residues 220-648) 
is shown as ribbon presentation and colored according to the diagrams. The signaling 
or S helix forms an extension of second HAMP domain helix. The switch loop is 
sensitive to the nucleotide binding state of the EAL domain and is involved for 
dimerization and catalysis in active phosphodiesterases. Two views, separated by a 
180° rotation, are shown.  
(B) The autoinhibitory latch. A close-up view of the S helix-EAL domain interface is 
shown with residues involved in direct, pair-wise interactions shown as sticks. Two 
views, separated by a 260° rotation, are shown. Helix α10 and the switch loop form a 
surface buttressing the S helix. 
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 The loop that connects the S helix to the GGDEF domain adopts a 
conformation that is identical to the linkage between active diguanylate cyclase 
domains and their regulatory domains (Fig. 3.10C). The conformation is stabilized by 
a salt bridge between two strictly conserved residues that are located at the beginning 
of the connecting loop and just upstream of the signature GGDEF motif (318RGGEF322 
in LapD), respectively: Asp239 in the loop and Arg316 in the GGDEF domain of LapD; 
Asp174 and Arg249 in WspR; Asp292 and Arg366 in PleD (16, 17, 34, 35). This 
interaction likely constraints the loop conformation, restricting the overall rotational 
freedom of the GGDEF domains relative to their associated regulatory modules, the S 
helix in the case of LapD and the response receiver domains in the case of PleD and 
WspR. 
In summary, the structural analysis of the cytoplasmic domain of LapD 
revealed that in the absence of c-di-GMP, the protein resides in an inhibited 
conformation, with the GGDEF domain forming a lid restricting access of c-di-GMP 
to the EAL domain. Nucleotide binding would disrupt this conformation likely 
accompanied by a major conformational change. 
 
Structural model of the on-state: Crystal structure of LapDEAL•c-di-GMP 
The crystal structure of LapDEAL bound to c-di-GMP was solved by molecular 
replacement (Table S1). We obtained crystals in two independent conditions yielding 
two different crystal forms (space group C2221, one molecule per asymmetric unit; 
and space group P6522, two molecules per asymmetric unit; Fig. 3.9B). While the 
majority of the crystal packing contacts were different, both crystal forms maintained 
a common dimer of EAL domains, and the resulting structures superimposed almost 
perfectly (rmsd of 0.6 Å over all atoms). 
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 Cyclic di-GMP binding preserved the overall conformation of the EAL 
domain observed in the apo-LapDdual structure (rmsd of 0.6 angstrom over all atoms) 
(Fig. 3.2), comparable to the lack of major conformational changes upon nucleotide 
binding to the EAL domains of YkuI and FimX (36, 37). Minor changes in the 
nucleotide-binding pocket are confined to four c-di-GMP-coordinating residues that 
adopt an alternate side chain rotamer conformation (Fig. 3.2A). 
The most notable conformational change upon c-di-GMP binding occurs in the 
switch loop (Fig. 3.2B). Nucleotide binding and the absence of the S helix allow the 
loop to restructure, resulting in the switching of the conserved phenylalanine residue 
F566 (Fig. 3.2B; Fig. 3.8). In apo-LapDdual, the side chain of F566 faces inward and is 
located at the center of the S helix-binding interface (Fig. 3.1B). In contrast, the 
switch loop adopts a conformation in the c-di-GMP-bound structure positioning F566 
so that it can participate in homodimerization (Fig. 3.2B and Fig. 3.3). The symmetric 
LapDEAL domain dimer is reminiscent of the oligomeric state in active EAL domain-
containing phosphodiesterases, such as in Pseudomonas aeruginosa SadR/RocR, 
Bacillus subtilis YkuI and the BLUF domain-regulated photoreceptor BlrP1 from 
Klebsiella pneumoniae, where dimerization is involved in positioning of the general 
base for efficient catalysis (Fig.11) (32, 33, 36). 
Most importantly, dimerization of the c-di-GMP-bound EAL domains is 
incompatible with the autoinhibited conformation observed in the crystals of LapDdual 
(Fig. 3.3C). The surface occupied by the S helix overlaps significantly with the 
homodimerization interface, which indicates that nucleotide-induced conformational 
changes will include the displacement the GGDEF domain and the S helix. More 
generally, the preservation of EAL domain dimerization in LapD and the 
conformational change of the switch loop upon c-di-GMP binding suggest their 
importance for signaling and regulation in GGDEF-EAL domain containing proteins. 
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Figure 3.2: Comparison between the nucleotide-free and c-di-GMP-bound EAL 
domain of LapD.  
(A) Crystal structure of LapDEAL•c-di-GMP. The c-di-GMP-bound structure of 
LapDEAL (gray) was superimposed onto the nucleotide-free structure of LapDdual 
(orange residues). The S helix and GGDEF domain were omitted for clarity. A close-
up view of the nucleotide binding pocket is shown with residues involved in c-di-
GMP binding presented as sticks. The (|Fo|-|Fc|) electron density map is shown as 
calculated from a model prior to inclusion of nucleotide and is contoured at 3.5σ.  
(B) Conformational change of the switch loop. Cyclic di-GMP binding and absence of 
the S helix allow the switch loop to adopt an alternative conformation (orange: apo-
LapDdual; gray: LapDEAL•c-di-GMP). As a consequence, the side chain of Phe566, a 
residue involved in both, S-helix interaction in LapDdual and dimerization of LapDEAL, 
changes position. 
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Figure 3.3: Dimerization of c-di-GMP-bound LapDEAL.  
(A) EAL domain dimerization. In both crystal forms obtained for LapDEAL•c-di-GMP 
we observe symmetric dimerization between protomers involving helix α10 and the 
switch loop. Dimerization buries 1350 Å2 of surface area (interface area times 2), and 
was predicted to be energetically favorable (31).  
(B) Dimer interface. A close-up view (left panel) and cartoon diagram (right panel) of 
the dimer interface is shown.  
(C) Comparison of apo-LapDdual and LapDEAL•c-di-GMP. The EAL domain from the 
crystal structure of nucleotide-free LapDdual was superimposed on one c-di-GMP-
bound EAL domain from dimeric LapDEAL. LapDdual is colored as shown in Fig. 3.1. 
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 Analysis of the autoinhibition and activation mechanism of LapD in solution 
Structure-guided mutations were introduced into LapD to assess the functional 
relevance of the autoinhibitory conformation and EAL domain dimerization (Fig. 
3.4A). Site-directed mutations were introduced into the S helix, predicted to weaken 
its interaction with the EAL domain without affecting EAL domain dimerization 
propensity (F222A, F222E, S229D, E230A or L232E; Fig. 3.1B). Another set of mutations 
targeted the GGDEF-EAL domain interface, focusing on changes in the GGDEF 
domain that would not interfere with EAL domain function (M252E, E262A or E333A; 
Fig. 3.10A). Finally, A602 was identified as a residue at the center of the EAL domain 
dimerization interface (Fig. 3.3B). The structure of apo-LapDdual showed A602 at the 
periphery of the S helix-EAL interaction, suggesting that perturbations at this site may 
maintain the autoinhibited state (Fig. 3.1B). To assess how buried the native residues 
are in the autoinhibited state, surface accessibility of their side chains was calculated 
based on the crystal structure of apo-LapDdual (Fig. 3.4B). 
First, we determined the effect of mutating representative residues on 
nucleotide binding to LapDdual protein variants. Following incubation with c-di-GMP, 
proteins were subjected to gel filtration for removal of unbound nucleotide. Eluted 
protein peaks were collected, concentrated, normalized for protein content, and heat 
denatured to release affinity-bound c-di-GMP. Filtered supernatants were analyzed by 
reverse-phase high-performance liquid chromatography (17), and c-di-GMP binding 
was compared to that of the wild-type protein (Fig. 3.4C). Both, a single-point 
mutation in the latch or one in the lip of the GGDEF domain that directly occludes the 
nucleotide pocket (S229D and E262A, respectively), increased c-di-GMP binding to 
LapDdual by twofold. In contrast, replacing A602 with a glutamate residue significantly 
reduced the amount of c-di-GMP bound to LapDdual, arguing toward cooperativity 
between nucleotide binding and EAL domain dimerization. Similar results were 
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 obtained for the isolated EAL domain mutant (Fig. 3.12B). 
We next analyzed the oligomerization state of LapDdual and LapDEAL protein 
variants in solution, by using static multi-angle laser scattering (Fig. 3.4D and 3.12B). 
This method provides the absolute molecular weight and hence quaternary structure of 
proteins eluting from a gel filtration column, and yields comparable results to 
analytical ultracentrifugation experiments in a significantly shorter experimental time 
frame (38). The wild-type LapDdual  protein elutes in a single peak from the size 
exclusion column with a molecular weight of 47.6 kDa, indicating a monomeric state 
in solution. Addition of c-di-GMP shifted the peak elution volume and increased the 
molecular weight slightly to 55.8 kDa, suggesting that nucleotide binding is 
accompanied by some degree of protein dimerization, although an additional change 
in molecular shape cannot be ruled out. Considering the c-di-GMP binding data, it is 
likely that only a fraction of LapD is bound to nucleotide under these conditions (Fig. 
3.4C).  
Both, the S helix-EAL and the GGDEF-EAL interface mutants (S229D and 
E262A, respectively) showed more distinct shifts in molecular weight upon c-di-GMP 
binding, being intermediate between pure monomers and dimers (Fig. 3.4D). In 
general, intermediate molecular weights and the non-gaussian peak shape, as observed 
for these samples, are indicative of a fast exchange between monomeric and dimeric 
species, relative to the data acquisition time. In the absence of c-di-GMP, the E262A 
and more so the S229D mutant proteins elute earlier compared to wild-type but were 
still predominantly monomeric, which is indicative of a more elongated conformation 
of these mutants in solution. As predicted on the basis of the structural analysis, 
LapDdual or LapDEAL containing a glutamate substitution in place of A602 are 
monomeric in solution, independent of the presence of nucleotide (Fig. 3.4D and 
3.12B). 
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Figure 3.4: Cyclic di-GMP binding and quaternary structure of LapDdual in 
solution.  
(A) Mutant categories. Structure-guided, site-directed mutants in LapD are illustrated. 
Mutations in brackets were used in experiments shown in Fig. 3.5 and Fig. 3.13.  
(B) Surface accessibility in LapDdual of residues targeted for mutagenesis. Based on 
the LapDdual crystal structure, surface accessibility of the side chains was calculated 
using naccess (39). The asterisk marks a residue at the center of the EAL domain 
dimerization interface.  
(C) Nucleotide binding to wild-type and mutant LapDdual. Purified LapDdual (wild-
type, S229D, E262A or A602E) was incubated in the presence of c-di-GMP. Excess 
nucleotide was removed by gel filtration, and protein-bound c-di-GMP levels were 
assessed by reverse-phase HPLC after heat-denaturation. Data are expressed relative 
to the amount bound to wild-type LapDdual.  
(D) Oligomerization of LapDdual in solution. Size exclusion chromatography (SEC)-
coupled multi-angle light scattering (MALS) analysis of wild-type and mutant 
LapDdual in presence and absence of c-di-GMP are shown. The signal from the 90°-
scattering detector is shown in color and the signal from the refractive index detector 
is shown as dashed line. Average molecular weights are plotted in black against the 
right Y-axis, as calculated every second across the protein elution peak. Theoretical 
molecular weights corresponding to those of a monomer and a dimer are indicated as 
horizontal dashed, grey lines. Injected protein and nucleotide concentrations were 250 
µM and 500 µM, respectively. 
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 In summary, LapD appears to be inhibited for efficient nucleotide binding by 
structural features involving the latch motif and occupancy of the c-di-GMP binding 
site by the GGDEF domain. Based on the observation that the A602E mutation, located 
in the EAL domain homodimer interface and outside of the c-di-GMP binding site, 
renders the protein monomeric and reduces nucleotide binding, we propose that 
dimerization and c-di-GMP binding are cooperative events in LapDdual and LapDEAL. 
It is important to note that LapD is a dimeric receptor via its HAMP and output 
domains, and therefore EAL domain dimerization (and nucleotide binding) is likely 
more pronounced in the context of the full-length receptor. 
 
Effect of structure-based mutations in LapD on biofilm formation 
Stable biofilms of Pseudomonas fluorescens require LapD expression and the 
presence of c-di-GMP (23). To examine the contribution of inter-domain interactions 
to LapD’s function in vivo, full-length LapD variants were assessed for their ability to 
promote biofilm formation in a ∆lapD mutant strain (Fig. 3.5A). We observed a range 
of phenotypes from a slight reduction in biofilm formation relative to the wild-type, to 
strong hyper-adherent phenotypes comparable to that observed when LapD is 
constitutively activated (Fig. 3.5A). The mutation that we predict to disrupt the S 
helix-EAL interface in the autoinhibited conformation, S229D, caused an ‘activated’ 
phenotype, consistent with its increased nucleotide binding and dimerization 
propensity in vitro (Fig. 3.4 and 3.5A). Similar results were obtained with the mutant 
F222E, whereas a less invasive alanine substitution was tolerated at this position. 
In the apo-LapDdual structure, the E262 residue is positioned such that it would 
occlude binding of c-di-GMP to the EAL domain (Fig. 3.10B). Consistent with this 
and its increased binding of c-di-GMP, the E262A mutation results in an increase in 
biofilm formation relative to the wild-type allele (Fig. 3.5A). Yet, the E262A mutant 
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 phenotype is not as extreme as that exhibited in the case of the S229D mutation, 
despite comparable increases in c-di-GMP binding and dimerization by these proteins 
in vitro. This suggests that the E262A mutant is still able to assume the auto-inhibited 
conformation in vivo, albeit at a lower threshold of c-di-GMP than the wild-type 
protein. Other mutations showed intermediate (L232E, M252E) or no significant 
changes (F222A, E230A, E333A) in phenotype, roughly corresponding to their surface 
exposure in the autoinhibited state structure (Fig. 3.4B and 3.5A).  
The A602E mutation, which disrupts the dimerization interface of the EAL 
domain and reduces steady state c-di-GMP binding in vitro (Fig. 3.4 and Fig. 3.12), 
led to a small but significant decrease in biofilm formation relative to the wild-type 
allele (Fig. 3.5A). The observation that the A602E mutant showed a minor loss-of-
function in vivo, distinct from the more pronounced loss-of-function observed with 
mutants in the nucleotide binding pocket (23), argues that dimerization increases the 
stability of the nucleotide-bound state rather than being required for c-di-GMP 
binding per se. While this modest reduction in function in vivo seemed incongruous 
with the severe defect in dimerization and binding exhibited by the dual-domain and 
EAL domain construct in vitro, we further tested its significance by introducing the 
A602E mutation into activated alleles of LapD, S229D and F222E, respectively. The 
reduction in biofilm formation in the double-mutants was substantial, corroborating 
that EAL domain dimerization plays a role in LapD function in vivo (Fig. 3.13A). 
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Figure 3.5: Phenotypic analyses of lapD mutants (Data courtesy of Peter D. Newell 
and George A. O’Toole). 
(A) Biofilm phenotypes. Biofilm formation of ∆lapD cell expressing full-length, wild-
type LapD, LapD point mutants or the insert-less expression vector was assessed. 
Crystal violet-stained biofilms (top) and their quantification (bottom) are shown. Data 
are means -/+ SD of 8 replicates. Protein levels were determined by Western blotting 
using a primary antibody that recognizes His6-epitope at the C-terminus of LapD. The 
asterisk marks a residue at the center of the EAL domain dimerization interface.  
(B) Phosphate-regulated c-di-GMP signaling. Phosphate starvation leads to the 
expression the active phosphodiesterase RapA and a reduction in cellular c-di-GMP 
concentration (23). LapD mutants were tested for their response to limiting phosphate 
concentration. Biofilm formation was monitored over 90 min after physiological 
activation of the Pho system in low-phosphate media, and compared to biofilm 
formation in phosphate-rich media. The mutant ∆H1 contains an activating deletion in 
the HAMP domain and has been described previously (23). 
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 The single-mutants were also tested for their response to phosphate starvation, 
a physiological input for LapD-mediated signaling (23, 40). Limiting phosphate 
availability activates the Pho system, which as part of its response upregulates the 
expression of a c-di-GMP-specific phosphodiesterase, RapA. Reducing cellular c-di-
GMP concentration downregulates wild-type LapD activity, which results in the 
release of the adhesin LapA from the cell surface and thus a reduction in biofilm 
formation (Fig. 3.5B, top) (23). Mutations in the S helix-EAL domain interface 
(F222E, S229D) or in the GGDEF lid that relieve occlusion of the c-di-GMP binding 
site failed to respond to phosphate starvation efficiently showing little to no reduction 
in biofilm formation (Fig. 3.5B). The effect was comparable to a deletion mutant 
described previously, in which a helical segment of the HAMP domain was removed, 
yielding a constitutively active, deregulated receptor (Fig. 3.5B) (23). Similar to the 
trends observed in the static biofilm assay (Fig. 3.5A), other mutants in LapD showed 
more subtle effects in the phosphate starvation experiments (Fig. 3.13B). 
Collectively, these results suggest that the S helix-EAL is the dominant 
autoinhibitory feature responsible for positioning the GGDEF domain to occlude the 
c-di-GMP-binding pocket. Together these two interfaces establish autoregulation and 
appropriate control of LapD activation in vivo. In addition, EAL domain dimerization 
via a conserved mode of interaction is likely to contribute to the efficiency of the 
signaling system by stabilizing the activated conformation. 
 
Crystal structure of LapD’s output domain: A conserved, domain-swapped 
periplasmic domain 
In order to shed light on how changes in the cytosolic domain are sensed in the 
periplasm, we determined the structure of the entire output domain (residues 22-151; 
Fig. 3.1A). The protein was purified to homogeneity by using standard 
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 chromatography procedures. Crystals grown with selenomethionine-derivatized 
protein were obtained by hanging drop vapor diffusion, and diffracted X-rays to a 
maximum resolution of 1.8 Å (Table S1). The structure was solved by single-
wavelength anomalous dispersion (SAD) phasing, using data collected at the selenium 
anomalous scattering peak wavelength. The final model consists of two molecules per 
asymmetric unit spanning residues 23-150 (Fig. 3.6A and 3.14A). 
The periplasmic output domain of LapD forms an extensively interweaved, 
domain-swapped dimer sharing 3429 Å2 interfacial surface area (1/3 of LapD’s output 
domain molecular surface) (Fig. 3.6A and 3.14B). The dimer adopts an overall V-
shaped conformation. Each arm of the fold consists of two α-helices and two β-
strands contributed by one of the two protomers, complemented by two β-strands 
flanked by helical segments from the other. The N- and C-terminal helices of LapD’s 
output domain presumably connect directly to the transmembrane helices and the 
HAMP domains. The two half-sites are linked via a long connecting segment that 
crosses over at the center of the dimer. The two protomers superimpose well except 
for a subtle rigid body rotation around the linker (Fig. 3.14A). 
A DALI search comparing LapD’s output domain to proteins in the PDB data 
base revealed structural similarity of its domain-swapped arms to the periplasmic 
domain of the sensor histidine kinase CitA (Z-score=5.4, rmsd of 2.5 Å) (41, 42). The 
periplasmic modules of CitA and related proteins show some homology to PAS 
domains and have been classified as PDC (PhoQ-DcuS-CitA) protein domains (43, 
44). Such domains occur in many other bacterial transmembrane proteins, but unlike 
LapD’s output domain, they are found to form a variety of regular, non-swapped 
dimers (42, 43, 45).  
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Figure 3.6: Structure-function analysis of the periplasmic output domain of 
LapD.  
(A) Crystal structure of LapDoutput. The crystal structure of the periplasmic output 
domain of LapD (residues 22-151) is shown as ribbon presentation with the two 
protomer chains colored in pink and gray, respectively. The relative position of the 
inner cell membrane (gray bar) and connection to the flanking transmembrane (TM) 
helices are indicated. Two orthogonal views are shown. (Protein expression and 
crystallization by Debashree Chatterjee; data collection and phase solution by Petya 
V. Krasteva; model building and refinement by Marcos V.A.S. Navarro and Holger 
Sondermann) 
(B) Topology diagram. The diagram illustrates the domain-swapped structure of the 
dimeric output domain.  
(C) Surface conservation. Based on an alignment of 18 sequences of LapD homologs, 
the sequence conservation was mapped onto the accessible surface of the output 
domain. One protomer is shown in surface presentation, the other is shown in ribbon 
presentation. Conserved motifs and individual residues are highlighted.  
(D) LapDoutput-LapG complex formation. Purified, hexahistidine-tagged LapG (His6-
LapG) was bound to NiNTA, and incubated in the absence or presence of untagged, 
wild-type LapDoutput, or a LapDoutput mutant in which W125 has been replaced with a 
glutamate. The Coomassie-stained gel shows eluates of NiNTA-bound proteins (data 
courtesy of Debashree Chatterjee).  
(E) Biofilm phenotypes and LapD stability. Biofilm formation of ∆lapD cell 
expressing full-length, wild-type LapD, LapD point mutants or the insert-less 
expression vector was assessed. Protein levels are shown by Western blotting for the 
His6-epitope at the C-terminus of LapD (Data courtesy of Peter D. Newell and George 
A. O’Toole). 
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 A sequence alignment of 18 sequences was constructed, including LapD 
homologs from other Pseudomonas strains but also extending to more distantly 
related sequences from other bacterial genera (Fig. 3.8; Table S2). Mapping sequence 
conservation onto the accessible molecular surface revealed a few potentially 
important patches (Fig. 3.6C and 3.15A). The PxWF and LW segments (residues 103-
106 and 144-145 of LapD, respectively) form a continuous surface at the bottom of 
the dimer. While the LW segment is part of the surface that accommodates the long 
N-terminal helix of the adjacent protomer, the PxWF is likely to interact with the 
inner membrane. The other striking feature is a strictly conserved loop connecting the 
strands β3 and β4 formed by the conserved GWxQ motif (residues 124-127 of LapD). 
W125 forms the most distal point of the periplasmic domain located at the center of the 
loop, and its side chain is in an outward facing rotamer conformation (Fig. 3.6C). 
Given its strict conservation and peculiar conformation, we targeted W125 in a 
site-directed mutagenesis, replacing its side chain non-conservatively with a 
glutamate residue. The mutant output domain expressed and purified 
indistinguishably from the wild-type protein but had distinct functional properties. In 
a purified system using hexahistidine-tagged LapG, a periplasmic cysteine protease 
that binds to LapD’s output domain in a c-di-GMP-dependent manner (27), we could 
efficiently pull-down the untagged wild-type output domain (Fig. 3.6D). This result 
indicates that in the absence of the transmembrane and cytoplasmic domains, the 
output domain adopts a LapG binding-competent state. In contrast, the output domain 
mutant W125E failed to interact with LapG in this assay. Consistent with these results, 
a full-length allele harboring the W125E mutation failed to restore LapD-dependent 
biofilm formation in a ∆lapD genetic background (Fig. 3.6E). The periplasmic loss-
of-function mutation is also dominant over the highly activating S229D mutation when 
introduced in the same allele, underlining the functional importance of W125 in 
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 transmitting cytosolic signaling events to the periplasm. 
 
Structure-based model for the regulation of periplasmic proteases in bacteria 
Our structural analyses of LapD revealed an autoinhibited conformation of the 
cytosolic domains in the absence of c-di-GMP, a dimeric state of c-di-GMP-bound 
EAL domains in the active state, and a domain-swapped dimer of the periplasmic 
output domain that is competent for LapG binding. The HAMP domain was modeled 
based on available structural information for this relay module, with the S helix 
forming a continuous extension of the HAMP domain’s second helix (46, 47). In 
conjunction with the biochemical and genetic analyses described in an accompanying 
manuscript, we propose the following model for the activation of LapD and its 
mechanism of inside-out signaling across the inner bacterial membrane (Fig. 3.7): The 
S helix and GGDEF domain function as a physical lock gating access of c-di-GMP to 
the EAL domain. In this conformation, LapD’s output domain is held in a LapG 
binding-incompetent state, and hence LapG gains access to and cleaves LapA, 
releasing this critical biofilm adhesin from the cell surface. An increase in the cellular 
c-di-GMP level will outcompete the inhibitory interactions in the cytoplasmic 
domains, likely accompanied by a large conformational change allowing EAL domain 
dimerization. Coupling between dimerization and c-di-GMP binding may further 
contribute to the efficiency of the activation switch, by preventing reversal to the 
autoinhibited state. Many mutations in the cytoplasmic module including the HAMP 
domain lead to aberrant, constitutive activation of LapD (Fig. 3.5) (23). These data 
suggest that intrinsic autoinhibitory interactions are indeed necessary to prevent the 
system from adopting a constitutively active conformation. 
The HAMP domain is directly coupled to the GGDEF and EAL domains via 
the S helix. HAMP domains occur in a large number of predominantly transmembrane 
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 sensor proteins that relay environmental signals to intracellular events (outside-in 
signaling). Rotation of the helices in HAMP dimers has been described as the main 
mechanism for signal transmission. It is conceivable that the release of the S helix 
from the EAL domain and associated events involving the GGDEF and EAL domains 
will trigger a rotation in the HAMP domain in a similar fashion, yielding a 
conformational change in the output domain and allowing it to sequester LapG. 
What is the relevance for the unusual fold of LapD’s output domain? Unlike 
CitA and related sensor proteins, which bind small molecules in the periplasm and 
relay this information to the inside of the cell, LapD sequesters a periplasmic protein 
upon receiving a cytosolic signal. We reason that a domain-swapped fold would 
respond more efficiently and precisely in coupling conformational changes in the 
cytosolic domains across the membrane, compared to canonical dimeric periplasmic 
domains. Given the functional importance and the particular position of W125, we 
hypothesize that the output domain may act as a molecular ruler with the tryptophan 
residues forming the tips of a caliper. Varying the angle between the arms of the V-
shaped fold upon c-di-GMP-triggered HAMP domain rotation could form the basis 
for modulating binding of LapG in the periplasm. 
 135
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Structure-based model for LapD inhibition and activation. (A) 
Structural model of full-length LapD. We derived models for the autoinhibited and 
activated, c-di-GMP-bound state of LapD based on the crystal structures described 
here. Only the c-di-GMP-bound receptor is capable of LapG binding in the periplasm. 
The HAMP domains were modeled based on sequence-alignments and available 
structural information (46, 47). The inset shows the predicted HAMP (and GGDEF) 
domain rotation associated with the activation of LapD. (B) Model for LapD-
mediated control of biofilm formation. The cartoon presents the current model for 
biofilm formation controlled by the c-di-GMP receptor LapD, based on our structural 
and functional analyses, previous results (23, 25-27). 
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 Although competent for specific LapG binding, the isolated LapD output 
domain failed to compete for LapG sequestration with the full-length c-di-GMP 
bound receptor (Newell, unpublished data). It is likely that the intracellular and 
transmembrane domains facilitate the formation of a stable, high-affinity state. The 
observation that the isolated output domain can bind LapG is consistent with a model 
in which the nucleotide-free intracellular domains hold the receptor in an 
autoinhibited conformation that relaxes into a LapG-binding state upon activation. 
Consequently, removal of the regulatory domains would allow for the output domain 
to adopt the active, LapG-binding conformation. In addition, potential higher-order 
oligomerization of LapD into lattices may contribute to sequestering LapG over larger 
membrane surfaces and to the fine-tuning of the signaling system. Two crystal 
structures described here, of the output domain and the c-di-GMP-bound EAL 
domain, show some potentially relevant higher-order interactions (Fig. 3.14C and 
3.14D). Further experiments will be required to determine the oligomeric state of full-
length LapD in the absence and presence of c-di-GMP. 
 
2.4. Conclusions 
Here, we elucidated the molecular mechanism underlying Pseudomonas 
fluorescens LapD function and regulation. Based on sequence conservation, LapD 
homologs in other Pseudomonas strains, including P. putida and P. aeruginosa, are 
likely to function in a similar fashion (Fig. 3.8; Table S2) (23, 24). While LapD and 
LapG from Pseudomonas aeruginosa (PA1433 and PA1434, respectively) show a 
high degree of sequence conservation and functionally rescue deletions in these genes 
in Pseudomonas fluorescens, no biofilm phenotype has been associated with this 
signaling system in their native strain (22, Newell- unpublished data), consistent with 
the absence of an obvious LapA homolog in this species. In contrast, we identified 
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 similar effector systems and targets in more distant genera including Legionella and 
various Vibrio strains. In all these bacteria, lapD and lapG homologs with conserved, 
functionally important residues exist within the same operon (Fig. 3.8; Table S2). 
LapD from Vibrio cholerae El Tor represents a special case since its EAL domain is 
encoded by a second gene, separated from the transmembrane receptor containing the 
output, HAMP and GGDEF domains. While the relevance of this finding requires 
further investigation, these genes have been found upregulated in rugose strains of 
Vibrio. cholerae, associated with increased biofilm formation (48).  
In most cases, the bioinformatic analysis also detected the presence of 
associated ABC transporters, as in the case of Pseudomonas fluorescens LapD. More 
variation is observed with regard to the putative substrates of the cysteine protease 
LapG. Newell et al. identified the large adhesin LapA as a LapG substrate, involved 
in biofilm formation and stability in Pseudomonas fluorescens. Based on the cleavage 
site sequence, other LapA homologs were identified in a variety of strains. In 
addition, we predict that LapG homologs may have different substrates in systems for 
which no clear LapA-type proteins could be identified. Proteins containing regions 
with homology to the LapG-cleavage site of LapA have been spotted in RTX-like 
bacterial toxins, and for the majority of such candidate substrates, these proteins are 
encoded in close genetic proximity to lapD and lapG homologs. 
The GGDEF-EAL domain-containing proteins described here are degenerate 
with respect to their active sites, lack catalytic activity, and function as c-di-GMP 
receptors. A similar system has been previously described in Escherichia coli. Unlike 
LapD, the transmembrane HAMP-GGDEF-EAL domain-containing protein CsrD 
regulates degradation of regulatory RNAs, but we speculate that the cytosolic module 
may be autoregulated in a similar fashion (49). Other proteins containing the tandem 
domain module with higher degree of conservation at the putative enzyme active sites 
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 exist in association with a HAMP domain in some bacterial genomes. The mechanism 
described for LapD may also be applicable to these systems, in which the HAMP 
domain and S-helix could be regulatory features to control the phosphodiesterase 
and/or diguanylate cyclase activity in outside-in signaling mechanism, thus leading to 
changes in cellular c-di-GMP levels. 
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 APPENDIX 
 
 
Supplemental Information 
 
S3.1. Materials and methods 
Protein expression and purification 
For in vivo experiments, LapD protein variants were expressed from an 
arabinose-inducible vector (pMQ72) in a ∆lapD strain as previously described (S1, 
S2). Proteins used in crystallization and in vitro studies were expressed and purified as 
follows. 
 The coding regions corresponding to the GGDEF-EAL dual domain module 
(LapDdual; residues 220-648) and to the isolated EAL domain (LapDEAL; residues 399-
648) of Pseudomonas fluorescens Pf0-1 LapD were amplified by standard PCR and 
cloned into a modified pProExHtb expression vector (Invitrogen), where the TEV 
protease cleavage site was engineered into a PreScission Protease site for removal of 
the N-terminally fused hexahistidine (His6) moiety. The coding region corresponding 
to the periplasmic output domain of LapD (LapDoutput; residues 22-151) was PCR-
amplified and cloned into a modified pET28a expression plasmid (Novagen) yielding 
an N-terminally His6-tagged SUMO fusion protein. The His6-tagged SUMO moiety 
was cleavable using the yeast protease Ulp-1. Finally, LapG protein was expressed as 
a C-terminally His6-tagged version after cloning and expression from a pET21a 
expression vector (Novagen).  
Native and selenomethionine-derivatized proteins were overexpressed in E. 
coli, as previously described (S3). Briefly, native proteins were expressed in T7 
Express cells (NEB), grown at 37˚C in Terrific Broth (TB) media supplemented with 
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 50 µg/ml kanamycin for the pET28a vector, or 100 µg/ml ampicillin for the pProEx 
and pET21 vectors. At an optical density corresponding to 0.8-1.2 absorbance at 600 
nm (OD600), the temperature was reduced to 18˚C and protein expression was induced 
with 1mM IPTG. Selenomethionine-derivatized proteins were expressed in T7 Crystal 
Express cells (NEB), grown in M9 minimal media supplemented with the appropriate 
antibiotic, vitamins (1 µg/ml thiamin and 1 µg/ml biotin), carbon source (0.4% 
glucose), trace elements, and amino acids (40 µg/ml of each of the 20 amino acids 
with selenomethionine substituting for methionine). Protein expression in minimal 
medium was induced at cell densities corresponding to OD600 of 0.4-0.5. After 16 
hours of expression at 18 degrees, cells were harvested by centrifugation, resuspended 
in NiNTA buffer A (25 mM Tris-HCl, pH 8.4, 500 mM NaCl, and 20 mM Imidazole), 
and flash-frozen in liquid nitrogen. 
After thawing and cell lysis by sonication, cellular debris were removed by 
centrifugation and clear lysates were incubated with NiNTA resin (Qiagen) 
equilibrated in NiNTA buffer A. The resin was washed excessively with buffer A and 
proteins were eluted in a single step of NiNTA buffer A supplemented with 500 mM 
Imidazole. Proteins were buffer exchanged into desalting buffer (25 mM Tris-HCl, pH 
8.4, 300 mM NaCl, and 5mM β-mercaptoethanol) and, where applicable, affinity tags 
were removed by incubation with the yeast protease Ulp-1 or PreScission Protease at 
4˚C overnight. Cleaved proteins were collected in the flow-through during a second 
step of NiNTA affinity chromatography (HisTrap; GE Healthcare). As final step of 
protein purification, proteins were concentrated and subjected to size-exclusion 
chromatography on a Superdex200 column (GE Healthcare) equilibrated with gel 
filtration buffer (25 mM Tris-HCl, pH 8.4, and 250-300 mM NaCl). Proteins were 
concentrated on a Centricon ultracentrifugation device with an appropriate molecular 
weight cut-off (Millipore) to final concentrations in the low milimolar range. Protein 
 148
 aliquots were flash frozen in liquid nitrogen and stored at -80˚C.  
 
Crystallization, X-ray data collection, and structure solving 
All crystals were obtained by hanging drop vapor diffusion after mixing equal 
volumes of protein (10-30 mg/ml) and reservoir solution. LapDdual was crystallized 
without cleavage of the N-terminally fused hexahistidine tag. Native and 
selenomethionine-derivatized proteins yielded single crystals grown at 20˚C with 
reservoir solution containing 14% PEG 4000 and 0.1 M MES, pH 6.0 (space group 
P32). In addition, LapDdual yielded crystals with I32 space group symmetry after 
mixing with reservoir solution of 0.2 M Ammonium acetate, 0.1 M Sodium citrate, 
pH 5.6, and 15% PEG 4000. For cryoprotection in either case, crystals were soaked in 
reservoir solution supplemented with 30% Ethylene glycol prior to freezing. 
For crystallization of the isolated, untagged EAL domain in the presence of c-
di-GMP, the protein solution was supplemented with 1mM purified nucleotide prior 
to setting up the crystallization trials. Diffraction-quality crystals with P6522 space 
group symmetry grew after incubation for 7-10 days at 4˚C with well solution 
containing 0.1 M Bis-Tris, pH 6.5, and 1.5 M Ammonium sulfate. Cyclic di-GMP 
bound EAL domain crystals with C2221 symmetry grew at 20˚C in a crystallization 
condition containing 0.1 M Bis-Tris, pH 5.5, 0.2 M Ammonium sulfate, and 24% 
PEG 3350. Prior to freezing, the crystals were soaked in their respective reservoir 
solutions supplemented with 25% of the cryoprotectant xylitol.  
LapDoutput crystals used for data collection were grown at 4˚C after mixing 
with a reservoir solution containing 22% PEG monomethyl ether 2,000 and 0.15 M 
Potassium bromide. For crystal freezing, the mother liquor was supplemented with 
20% xylitol to ensure cryoprotection.  
Cryo-preserved crystals for all protein constructs were flash-frozen and stored 
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 in liquid nitrogen. Data were collected on frozen crystals at 100K using synchrotron 
radiation at the Cornell High Energy Synchrotron Source (CHESS). 
Data reduction was carried out with the software package HKL2000 (S4) and 
XDS (S5). Experimental phases for LapDdual and LapDoutput crystals were obtained 
from Single Anomalous Diffraction (SAD) experiments on crystals grown from 
selenomethionine-derivatized proteins. Heavy atom positions and solvent flattening 
was carried out by using the software package PHENIX (S6). For LapDdual, initial 
phases were extended by using the software DM (S7), and the first model was built 
into the electron density map automatically by using the software Buccaneer (S8). The 
structure of nucleotide-bound LapDEAL was determined by molecular replacement in 
PHENIX with the EAL domain of LapDdual as the search model. Refinement in 
PHENIX and COOT yielded the final models (S6, S9). Data collection and refinement 
statistics are summarized in Table S1. Illustrations were made in Pymol (DeLano 
Scientific). 
 
Size exclusion chromatography-coupled static multi-angle light scattering (MALS) 
For MALS measurements, purified proteins (250 µM; injected concentration) 
were subjected to size exclusion chromatography (SEC) using a Shodex KW-803 
column (JM Science) equilibrated in gel filtration buffer (25 mM Tris-HCl pH 8.4 and 
250 mM NaCl). Where specified, wild-type or mutant LapD protein variants were 
incubated with c-di-GMP (500 µM), produced enzymatically (see below), for 30 
minutes at room temperature prior to SEC. The SEC system was coupled to a three-
angle light scattering detector and a refractive index detector (miniDAWN TREOS 
and Optilab rEX, respectively, Wyatt Technology). Data were collected every second 
at a flow rate of 0.5 ml/min and analyzed with the software ASTRA, yielding the 
molecular weight and mass distribution (polydispersity) of the samples. For data 
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 quality control and normalization of the light scattering detectors, monomeric bovine 
serum albumin (Sigma) was used. 
 
Enzymatic production of c-di-GMP 
Cyclic di-GMP used in crystallization trials and c-di-GMP binding assays was 
synthesized enzymatically using a constitutively active WspR mutant (PA3702 R242A) 
and GTP as a substrate (S10). Following purification by preparative reverse-phase 
HPLC and lyophilization, the nucleotide product was enzymatically tested as a 
substrate for phosphodiesterases (data not shown). Cyclic di-GMP purity and 
concentration were determined based on absorbance at 254 nm in comparison with 
commercially obtained standard (Biolog Life Science Institute). 
 
Semi-quantitative c-di-GMP binding assay  
Proteins (250 µM) were preincubated with excess c-di-GMP (500 µM) and 
separated from unbound nucleotide via SEC. SEC-eluted protein peaks were 
collected, concentrated to a final concentration of 200 µM to normalize for protein 
content, heat denatured and filtered through Microcon Centrigugal Filter Units 
(Millipore, 10 kDa cut-off). Nucleotide content in the resulting samples was analyzed 
on a C18 reverse-phase HPLC column by using a methanol-phosphate gradient 
(buffer A: 100mM monobasic potassium phosphate pH 6.0; buffer B: 70% buffer A, 
30% methanol) (S10). Purified nucleotides were used for standardization. Integrated 
areas of the c-di-GMP peaks from three independent experiments were plotted as 
relative to those for the wild-type LapDdual and LapDEAL protein constructs, 
respectively. 
 
Protein pull-down assay 
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 Hexahistidine (His6)-tagged LapG was incubated with NiNTA superflow resin 
(Qiagen) in low-salt binding buffer (25 mM Tris-HCl pH 8.4, 75 mM NaCl, 25 mM 
KCl, and 40 mM Imidazole). After removal of any unbound protein in consecutive 
wash steps, untagged LapD output domain variants were added to the reaction and 
incubated for 1 hour at 4ºC under nutation. The resin was extensively washed in low-
salt binding buffer. The remaining affinity-bound proteins or protein complexes were 
eluted from the slurry in elution buffer (25 mM Tris-HCl pH 8.4, 500 mM NaCl, 300 
mM Imidazole) and visualized using standard denaturing gel electrophoresis (SDS-
PAGE). 
 
Strains and growth conditions 
Routine culturing of P. fluorescens Pf0-1 and E. coli was done in lysogeny 
broth (LB) at 30°C and 37°C, respectively. When appropriate, antibiotics were added 
to the medium at the following concentrations: E. coli- 10 µg/ml Gentamycin; P. 
fluorescens- 20 µg/ml Gentamycin. Plasmids were introduced into P. fluorescens by 
electroporation as described (S11). K10T media for biofilm assays was prepared as 
described (S12): K10T-π: 50 mM Tris-HCl pH 7.4, 0.2% (wt/vol) Bacto tryptone, 
0.15% (vol/vol) glycerol, and 0.61 mM Mg2SO4. K10T-1 medium is K10T-π 
amended with 1 mM K2HPO4. A list of strains and plasmids used in the cell-based 
assays is provided as Supplemental Table 3. 
 
Construction of LapD variants  
For in vitro studies, ladD point mutants were generated using QuikChange site 
directed mutagenesis kit (Stratagene) following the manufacturer’s instructions. For 
cell-based studies, lapD alleles were generated by recombination cloning (S2). 
Briefly, lapD was amplified in two pieces, the 5’ fragment ending just upstream of the 
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 codon to be changed and the 3’ fragment beginning just downstream. The new codon 
and 21 complimentary bases were included in each internal primer such that 
recombination in yeast with the parent pMQ72 vector would yield a contiguous lapD 
ORF with the desired codon change. 
 
Quantitative biofilm formation and surface attachment assays 
To quantify biofilm formation, strains were grown statically for 6 hours in 
K10T-1 medium as described previously (S1). Biofilm biomass was stained with 0.1% 
crystal violet for 15 min, and stain dissolved and quantified by spectrophotometry, 
measuring O.D. at 550nm. We analyzed the effects of Pi starvation on attachment by 
comparing biofilm levels in high Pi (K10T-1) and low Pi (K10T-π) media over time, 
as done previously (S1). 
 
Assessment of LapD protein levels by Western blot 
LapD proteins expressed in P. fluorescens Pf0-1 were visualized by Western 
blot as described previously (S1), with the following modifications. Blots were probed 
for the His6-epitope with a rabbit anti-His6 antibody (Genscript). Samples consisted of 
clarified cell lysates prepared by harvesting cells from 3 ml of overnight culture, 
sonicating 3 x 10s in 500 µl of buffer (20 mM Tris pH 8, 10 mM MgCl2), and 
pelleting debris at 15,000 x g for 12 min. Samples were normalized to protein 
concentration using the BCA kit (Pierce).  
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 S3.2. Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Sequence alignment of LapD homologs. 
A sequence alignment of LapD homologs from various species was generated with 
ClustalW2 (S13) and formatted with ESPript (S14). Key residues discussed in the 
manuscript are marked with closed, green arrows. The degenerate GGDEF and EAL 
signature motifs (RGGEF and KVL, respectively) are marked with yellow bars. 
Secondary structure elements are shown based on the crystallographic data and 
secondary structure predictions for the transmembrane and HAMP domains. The 
following sequences were used to generate the alignment: Pseudomonas fluorescens 
Pf0-1 (LapD, YP_345864), Pseudomonas putida KT2440 (NP_742334), 
Pseudomonas aeruginosa PA01 (NP_250124), Pectobacterium carotovorum subsp. 
brasiliensis PBR1692 (ZP_03826388), Citrobacter sp. ATCC 29220 (ZP_06355256), 
Polaromonas sp. JS666 (YP_547171), Rhodoferax ferrireducens T118 (YP_524995), 
Dechloromonas aromatica RCB (YP_286553), Cellvibrio japonicus Ueda107 
(YP_001981887), Legionella pneumophila str. Lens (YP_126219), Geobacter sp. 
M18 (ZP_05313414), Vibrio alginolyticus 12G01 (ZP_01258281), Vibrio 
parahaemolyticus AQ3810 (ZP_01990882), Vibrio harveyi HY01 (ZP_01986262), 
Vibrio shilonii AK1 (ZP_01866121), Vibrio cholerae 1587 (ZP_01950486), Vibrio 
fischeri ES114 (YP_207124), Vibrio angustum S14 (ZP_01233947). 
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Figure 3.9: Crystal forms of LapDdual and LapDEAL•c-di-GMP.  
(A) LapDdual. Two independent crystal forms were obtained for LapDdual. The 
resulting structures were superimposed on the EAL domain and shown as protein 
backbone traces (Data courtesy of Marcos V.A.S. Navarro).  
(B) Cyclic di-GMP-bound LapDEAL. Two independent crystal forms were obtained 
for LapDEAL. Both crystal lattices show the same dimeric assembly of EAL domains. 
Dimers were superimposed on one EAL domain and shown as protein backbone 
traces. 
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Figure 3.10: GGDEF-EAL domain interactions and S helix-GGDEF domain 
linker conformation observed in apo-LapDdual (Data courtesy of Marcos V.A.S. 
Navarro).  
(A) GGDEF-EAL domain interaction. Close-up views are shown for regions of direct 
contact between the GGDEF and EAL domains in the autoinhibited structure of 
LapDdual. The GGDEF and EAL domain is colored in green and orange, respectively. 
The S helix is colored in blue.  
(B) Nucleotide binding pocket in apo-LapDdual. A close-up view of the c-di-GMP 
binding pocket of LapD is shown (right panel). Cyclic di-GMP is shown in stick 
presentation after superimposing the crystal structure of LapDEAL•c-di-GMP onto the 
EAL domain of apo-LapDdual. The interacting residue pair R450/E262 in LapD is 
incompatible with c-di-GMP binding. The left panels show surface presentations of 
apo-LapDdual. The middle panel shows accessibility of the c-di-GMP binding site, 
with c-di-GMP taken from LapDEAL•c-di-GMP after superimposition.  
(C) S helix-GGDEF connector. The S helix and the GGDEF domain are connected 
via a short loop that forms a tight turn. The loop conformation is conserved in other 
GGDEF domain-containing proteins, and is stabilized by the interaction between two 
residues, D239 and R316, which are strictly conserved in many GGDEF domain-
containing proteins (S10, S15-S17). The arginine residue is directly preceding the 
GGDEF domain signature motif (GGDEF or GGEEF in active cyclases; RGGEF in 
LapD), the aspartate residue is located at the N-terminus of the loop. Its strict 
sequence and conformational conservation suggest a functional importance of the 
connector loop, likely restricting the conformational freedom between adjacent 
domains. 
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Figure 3.11: Comparison of c-di-GMP-bound LapDEAL and YkuI dimers.  
(A) Overview. Structures of EAL domain dimers of LapD and YkuI bound to c-di-
GMP are shown in ribbon presentation (S18). Cyclic di-GMP is shown in stick 
presentation. Structures were superimposed on one of the EAL domain of the dimeric 
assemblies.  
(B) Cyclic di-GMP binding site. A close-up view of the nucleotide binding pocket is 
shown. Residues involved in c-di-GMP (and, in the case of YkuI, divalent cation) 
coordination are shown in stick presentation. 
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Figure 3.12: Cyclic di-GMP binding and quaternary structure of LapDEAL in 
solution.  
(A) Oligomerization in solution. Size exclusion chromatography (SEC)-coupled 
multi-angle light scattering (MALS) analysis of wild-type and mutant LapDEAL in the 
presence and absence of c-di-GMP are shown. The signal from the 90°-scattering 
detector is shown in color and the signal from the refractive index detector is shown 
as dashed line. Average molecular weights are plotted in black against the right Y-
axis, as calculated every second across the protein elution peak. Theoretical molecular 
weights corresponding to those of a monomer and a dimer are indicated as horizontal 
dashed, grey lines. Injected protein and nucleotide concentrations were 250 µM and 
500 µM, respectively.  
(B) Cyclic di-GMP binding. Purified LapDEAL (wild-type or A602E) was incubated in 
the presence of c-di-GMP. Excess nucleotide was removed by gel filtration, and 
protein-bound c-di-GMP levels were assessed by reverse-phase HPLC after 
normalization for protein content and heat-denaturation. Data are expressed relative to 
the amount of c-di-GMP bound to wild-type LapDEAL. 
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Figure 3.13: Phenotypic analyses of lapD mutants (Data courtesy of Peter D. 
Newell and George A. O’Toole).  
(A) Biofilm phenotypes of double-mutants. Biofilm formation of ∆lapD cells 
expressing full-length, wild-type LapD or LapD point mutants was assessed. 
Quantification of crystal violet-stained biofilms is shown. Data are means -/+ SD of 8 
replicates. Protein levels were determined by Western blotting using a primary 
antibody that recognizes the His6-epitope at the C-terminus of LapD.  
(B) Phosphate-regulated c-di-GMP signaling. Phosphate starvation leads to the 
expression the active phosphodiesterase RapA and a reduction in cellular c-di-GMP 
concentration (S1). LapD mutants were tested for their response to limiting phosphate 
concentration. Biofilm formation was monitored over 90 min after activation of the 
Pho system upon transfer to low-phosphate media, and compared to biofilm formation 
in phosphate-rich media. The mutant ∆H1 contains an activating deletion in the 
HAMP domain and has been described previously (S1). Mutants assessed for biofilm 
formation in Figure 5A but not included in Figure 5B are shown. 
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Figure 3.14: Structural analysis of LapDoutput and potential mechanisms for 
higher-order oligomerization of LapD.  
(A) Comparison between LapDoutput protomers. The periplasmic output domain of 
LapD crystallized with two molecules in the asymmetric unit. The protomers were 
superimposed on the first two helices of the fold, revealing a minor, rigid-body 
rotation of one half of the molecule relative to the other half between the two 
protomers. The rotation occurs at the connecting loop between β2 and α3 that forms 
the crossing-over point in the domain-swapped dimer.  
(B) LapDoutput crystal packing. Domain-swapped dimers of the output domain interact 
predominantly via two interfaces in the crystal lattices. One involves bottom-to-
bottom interaction between LapDoutput dimers via a conserved, hydrophobic patch 
coinciding with the putative membrane-interaction surface. The other interface 
involves hydrophobic interactions between the arms of the V-shaped output domain 
dimers.  
(C) Potential higher-order oligomerization based on the structure of LapDoutput. 
Crystal lattice contacts reveal a potential mode for higher-order assemblies of LapD. 
The close-up view (right panel) shows the hydrophobic contacts between output 
domain dimers.  
(D) Potential higher-order oligomerization based on the structure of LapDEAL•c-di-
GMP. In the C2221 crystal lattice, EAL domains form higher-order lattices that may 
highlight a mode for receptor oligomerization in the membrane. 
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Figure 3.15: Surface conservation and hydrophobicity of LapDoutput.  
(A) Surface conservation. Based on an alignment of 18 sequences of LapD homologs 
(Fig. 3.8), the sequence conservation was mapped onto the solvent-accessible surface 
of the output domain. One protomer is shown in surface presentation, the other is 
shown in ribbon presentation. Conserved motifs and individual residues are 
highlighted. Two views, separated by a 180° rotation, are shown.  
(B) Hydrophobicity mapped onto the molecular surface of LapDoutput. The surface is 
colored according to the hydrophobicity of accessible residues. Hydrophobic residues 
are shown in green, polar and charged residues are in gray and pink, respectively. 
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 S3.3. Supplemental Tables  
Table S1: X-ray data collection and refinement statistics 
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 Table S2: Conservation of the LapD/LapG signaling system 
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 CHAPTER  IV 
 
 
Conclusions 
 
Bacterial pathogenesis involves collaborative group behaviors such as quorum 
sensing, swarming, and biofilm formation. While prevalent quorum sensing correlates 
with virulence gene expression and acute-phase infections, biofilm formation allows 
for the development of chronic infections and microbial survival in hostile 
environments (1, 2). It has been appreciated only recently that these social behaviors 
are highly regulated developmental processes involving strictly coordinated inter- and 
intracellular signaling mechanisms. Cyclic di-GMP, an intracellular second messenger 
unique to the bacterial world, has emerged as a key regulator of the various processes 
involved in the initiation, progression, and dispersal of bacterial biofilms (3, 4). 
Diguanylate cyclases containing GGDEF domains and phosphodiesterases containing 
either EAL or HD-GYP domains have been identified as the enzymes controlling 
cellular c-di-GMP levels, yet little is known regarding signal transmission and the 
sensory targets of c-di-GMP (5, 6).   
Comparative genomic analyses have been instrumental for the characterization 
of the various c-di-GMP turnover domains in bacteria (6-9). The available complete 
sequences of scores of bacterial genomes– and therefore possible cross-genome 
sequence alignments– have helped identify and predict the metabolic function of a 
number of signaling modules based on conserved sequence motifs, predicted 
secondary structure or domain organization, inter- and intraoperon genetic 
environment, and phylogenetic patterns of cross-species evolution (6). GGDEF, EAL, 
and HD-GYP domains have thus been characterized as some of the most abundant 
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 protein modules encoded by bacterial genomes, with their representation per species 
roughly correlating with the organisms’ adaptational capacities (5, 6). The 
nomenclature of these c-di-GMP turnover domains is also a direct result of 
comparative sequence analyses: GGDEF, EAL, and HD-GYP correspond to 
characteristic conserved amino acid motifs found in the corresponding signaling 
modules (6-9). 
Similar bioinformatic analysis identified PilZ domains as protein modules 
involved in various c-di-GMP signaling pathways and predicted that they might 
function as direct sensors relaying the second messenger’s input (10). Further 
experimental evidence has corroborated c-di-GMP binding to several PilZ domain-
containing proteins, as well as their direct involvement in biofilm formation or 
expression of virulence determinants (11-15).  
Interestingly, many bacteria that utilize c-di-GMP mediated signaling for 
adaptation lack PilZ domains encoded in their genomes (10). In addition, in some 
organisms PilZ signaling modules seem to control some, but not all of the c-di-GMP 
dependent processes involved in biofilm formation and pathogenicity. For example, 
while PilZ domain-containing proteins in Vibrio cholerae are not essential for 
rugosity and exopolysaccharide production, some of them are required for efficient 
intestinal colonization during environment-to-host transition (13, 16).  
It has thus become increasingly evident that the gamut of bacterial c-di-GMP 
receptors spreads far beyond the family of PilZ protein domains. Identified c-di-GMP 
sensors include bacterial riboswitches, transcription factors of various domain 
architectures, divergent c-di-GMP turnover domains, and allosteric sites on active or 
degenerate diguanylate cyclases (16-25). Interestingly, some of the identified c-di-
GMP targets belong to protein families generally involved in sensing or metabolizing 
different nucleotide-based small molecules. For example, FleQ of Pseudomonas 
 175
 aeruginosa belongs to the AAA+ superfamily of ATPases, but seems to function as a 
c-di-GMP signal effector independent of ATP binding or hydrolysis (18). Similarly, 
Clp of Xanthomonas campestris is classified as a catabolite activator-like protein, 
whose homolog in Escherichia coli regulates gene expression in a cAMP-dependent 
manner (20, 26). On one hand this highlights the functional complexity and rapid 
evolution of homologous proteins in bacterial signaling networks. On the other, it is 
somewhat expected based on the fact that c-di-GMP turnover domains are themselves 
homologous to protein domains involved in the synthesis or hydrolysis of different 
nucleic acid-based metabolites. For example, while GGDEF domains are evolutionary 
close to adenylate cyclases (9), HD-GYP domains belong to the larger HD 
superfamily of phosphohydrolases with nucleotide-based substrates such as dGTP or 
ppGpp (6). This raises the question whether there are a limited number of universal c-
di-GMP binding motifs and/or protein folds, or individual c-di-GMP receptors have 
evolved specific modes of recognition to ensure signal isolation. The two scenarios 
are not mutually exclusive and bioinformatic analyses based on sequence alignments 
and available structural data has so far been able to identify some common c-di-GMP 
binding features. These include the abovementioned PilZ domains (10), a prevalent 
riboswitch class in bacterial messenger RNAs (17), the characteristic I-site RxxD 
motifs on degenerate (PelD of Pseudomonas aeruginosa, CdgG of Vibrio cholerae) or 
active (PleD of Caulobacter crescentus, WspR of Pseudomonas aeruginosa) GGDEF 
modules (16, 23-25, 27), as well as the potential for catalytically inactive EAL 
domains to serve as c-di-GMP sensors (FimX of Pseudomonas aeruginosa, LapD of 
Pseudomonas fluorescens) (21, 22). It is nevertheless important to note the following: 
first, not all members of the abovementioned classes of potential c-di-GMP receptors 
would serve as such in vivo; second, the diversity of protein domain architectures, 
putative domain-domain interactions, and adopted c-di-GMP conformations 
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 complicates prediction-based approaches for the identification of novel c-di-GMP 
receptors; third, many of the identified c-di-GMP sensors are so-far stand-alone 
representatives with uncharacterized mode of nucleotide recognition (FleQ of 
Pseudomonas aeruginosa, Clp of Xanthomonas campestris) (18, 20, 26); and forth, 
other classes of c-di-GMP receptors are likely to exist in nature.    
Here we set out to identify and provide detailed mechanistic analyses of 
several putative or known c-di-GMP receptors. We identified VpsT of V. cholerae as 
a novel c-di-GMP receptor and presented the crystal structures of the c-di-GMP • free 
and nucleotide-bound states (Chapter II). As a response regulator with an N-terminal 
receiver domain and a C-terminal helix-turn-helix DNA-binding module, VpsT differs 
from previously identified c-di-GMP receptors and underscores the diversity of the 
second messenger’s targets. Our structural and functional studies provided 
comprehensive characterization of the protein’s c-di-GMPp•pdependent oligomerization 
propensity and its relevance as a mechanism for signal integration and global 
transcription control. Based on our analyses, we defined a novel structural class of 
receiver domain proteins, likely utilizing a distinct structural feature to dimerize upon 
signaling inputs with or without concurrent phosphorylation events. In addition, we 
were able to propose a model for VpsT-mediated changes in DNA architecture, and 
outlined a number of future experiments that would prove or disprove our hypotheses 
(Chapter II, Appendices A and B). Thus, our collaborative interdisciplinary approach 
provided for the first time in the literature an in-depth structural and functional 
analysis of a global transcription regulator able to inversely control the production of 
extracellular matrix and flagellar motility under direct c-di-GMP signaling input. 
Our initial interest in VpsT as a putative c-di-GMP sensor has been largely 
based on its homology to CsgD from Escherichia coli and Salmonella typhimurium, a 
protein whose expression and function are tightly intertwined with various c-di-GMP 
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 signaling pathways (28, 29). In addition, CsgD has been postulated to be incompetent 
for phosphotransfer and to instead be dependent on small molecule binding for 
efficient gene expression regulation (29, 30). Based on the crystal structure of the 
VpsT • c-di-GMP complex and on nucleotide-binding studies on CsgD in vitro, we 
determined that CsgD contains a divergent c-di-GMP • binding site and is uncapable of 
c-di-GMP recognition (data not shown). Whether the protein binds c-di-GMP or 
another small molecule in vivo remains so-far unknown. A recent study has proposed 
that CsgD could be nevertheless regulated by phosphorylation, as the protein 
autophosphorylates in the presence of high concentrations (10mM) of acetyl 
phosphate in vitro (31). While such phosphorylation appears to inhibit protein binding 
to its cognate DNA, it remains unclear whether this is due to a distinct functional state 
or is an artifact of non-specific binding and reduced protein stability. In support of the 
latter, acetyl phosphate does not affect CsgD function in vivo and a loss-of-function 
asparagine substitution of the conserved phosphoreceiver aspartate (D59N) preserves 
phosphate binding to the protein in vitro (31). In addition, a phosphomimetic aspartate 
to glutamate substitution (D59E) appears to inactivate the protein, but the mutant is 
indeed characterized by markedly reduced protein stability (31). Based on our 
structural studies on VpsT (19), phosphoreceiver D59 is likely proximal to a 
dimerization interface, disruption of which might explain the mutant’s altered stability 
and function and account for the observed effects in vitro and in vivo.  
Althouhg data available on the regulation of CsgD in vivo remains scarce and 
inconclusive, it is clear that the FixJ/LuxR/CsgD family of response regulators has 
evolved an array of diverse regulatory sensitivities. Based on our structural studies 
and comparative sequence analysis, we were able to identify conserved structural 
features (α6-dimerization, c-di-GMP coordinating residues, residues connecting the 
phosphoreceiver site with the nucleotide-binding pocket) that could shed light on the 
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 evolution from archetypal two-component phosphotransfer to small molecule 
recognition and facilitate the prediction of additional c-di-GMP targets. Such putative 
c-di-GMP receptors include VC0396, a VpsT homolog encoded by the Vibrio 
cholerae genome with a functional c-di-GMP binding motif (data not shown), and 
PA0533, a PAS domain-containing homolog in the opportunistic pathogen 
Pseudomonas aeruginosa. 
Similarly to VpsT, FleQ of Pseudomonas aeruginosa is a transcription 
regulator which inversely regulates flagellar motility and exopolysaccharide 
production upon direct c-di-GMP recognition (18). Since structural data regarding the 
exact mechanism of this nucleotide-dependent switch is currently unavailable, we set 
out to determine the crystal structures of its c-di-GMPp•pbound and nucleotide-free 
states. To this end, we have crystallized a functional protein construct in the presence 
of c-di-GMP and have obtained an experimental phase solution at 3.33 Å resolution 
(Chapter II, Appendix B). While further model building and refinement will be 
necessary for the identification of functionally important residues and the ligand 
recognition motif, we are confident that our studies will help expand the list of 
putative c-di-GMP receptors and will shed light on the function of biologically 
important homologs. Among those is Vibrio cholerae VpsR, an essential partner of 
VpsT in the regulation of rugosity and biofilm formation (32). 
Besides regulators of gene expression, c-di-GMP sensors include proteins with 
degenerate c-di-GMP turnover domains. One such protein is LapD of Pseudomonas 
fluorescens (22): a transmembrane receptor that contains a conserved HAMP-
GGDEF-EAL domain intracellular module, which senses cellular c-di-GMP levels 
and controls the conformation of the periplasmic output domain. Interaction of c-di-
GMP bound LapD with the periplasmic protease LapG is crucial for maintenance of 
the surface adhesin LapA and leads to stable biofilm formation (33). Based on three 
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 novel structures, solution biophysical and biochemical studies, as well as cell based 
phenotypic assays, we presented a model for the autoinhibition and activation of 
LapD in response to its ligand availability (Chapter III). In addition, we identified 
many features and functionally important motifs to be conserved in a diverse range of 
free-living and pathogenic species, where homologous systems of inside-out signaling 
are likely to control biofilm formation or toxin expression. 
In summary, by using structural biology methods we were able to determine 
the atomic resolution structures and conformational states of several c-di-GMP 
receptors, members of various protein families in terms of both conserved domain 
organization and level of functional impact. We then used these molecular snapshots 
to guide our research into the proteins’ function as signal integrators in the big picture 
of intracellular signaling networks. We identified functional motifs and protein 
interfaces likely to apply to homologs in a variety of species and thus provided basis 
for future cross-genome comparative studies and targeted function assessments. We 
believe that the results of our studies provide valuable information about c-di-GMP 
mediated virulence and adaptation, as well as, in the long term, targets for the 
development of novel therapeutics against bacterial infections.  
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